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Burkholderia pseudomallei is the causative agent of melioidosis—an endemic 
disease in the Southeast Asia and Northern Australia. Infections can result in clinical 
manifestations ranging from asymptomatic, chronic suppurative infection to potentially 
fatal septicemia. The aim of this project is to study the host responses and factors which 
contribute to resistance or susceptibility in two strains of mice showing differential 
responses to B. pseudomallei infection. We found that BALB/c mice were highly 
susceptible to low dose intranasal B. pseudomallei infection. They developed acute 
disease and died within 2 weeks, whereas C57BL/6 mice were relatively resistant. 
Susceptibility of BALB/c mice correlates with high bacterial loads in the lung and spleen, 
infiltration of leukocytes (especially neutrophils), tissue pathology (in the lung and 
spleen), and hyper-inflammation. A transient hyperproduction of IFN-γ was found at 48h 
post-infection in the serum of BALB/c, but not in the relatively resistant C57BL/6 mice. 
C57BL/6 did not show a complete resistance to infection, as high dose B. pseudomallei 
infected C57BL/6 mice died of septicemia resembling the characteristics of low dose 
infected BALB/c mice. C57BL/6 mice which survived after an initial infection were 
found to be resistant to subsequent low dose or high dose challenge. Resistance of low 
dose immunized C57BL/6 mice to high dose infection correlated to high serum IgG2a, 
which was indirect evidence of IFN-γ induced cell-mediated immunity, and with a low 
IgG1 response. In contrast, BALB/c mice immunized with recombinant flagellin (r-FliC) 
induced high serum IgG1, which did not confer protection against B. pseudomallei 
infecton. However, some low dose infected and all high dose infected C57BL/6 mice 
eventually developed splenic abscesses and died at much later time points.   
 x
 In vitro study showed that naïve BALB/c splenocytes produced higher IFN-γ 
than naïve C57BL/6 splenocytes in response to B. pseudomallei infection, mirroring what 
was seen in vivo. Splenocytes from BALB/c mice contained higher number of 
intracellular bacteria than C57BL/6, which could explain why they made more IFN-γ. 
The IFN-γ response was IL-12 dependent and IL-18 could have a synergistic effect, while 
IL-10 ameliorated the IFN-γ response.  There was no obvious difference in the cell types 
making IFN-γ in BALB/c and C57BL/6 splenocytes. In both strains of mice, Gr-1 
positive cells (particularly the CD8+ T lymphocytes and DX5+ NK cells), and CD4+ cells 
were the major producers of the IFN-γ in response to B. pseudomallei. BALB/c 
splenocytes also contained higher numbers of Gr-1intermediate expressing NK and CD8+ 
cells. Using splenocytes from nude mice, the redundancy of T cells in IFN-γ response of 
splenocytes to B. pseudomallei was observed. TLR-4 signaling was found to be essential 
for IFN-γ response of splenocytes to the heat-killed bacteria, but not for the response to 
live bacteria. Besides hyperproduction of IFN-γ, BALB/c mice produced more TNF-α, 
IL-1β, IL-6, higher basal IL-18, and more anti-inflammatory cytokine (IL-10) compared 
to the splenocytes of C57BL/6 mice. This study suggests that resistance to infection lies 
in the innate ability to control the bacterial growth that allows subsequent development of 
adaptive immunity. Despite the importance of IFN-γ for host resistance, uncontrolled 
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Melioidosis is a life-threatening disease affecting both human and animals caused 
by the Gram-negative bacteria, Burkholderia pseudomallei. It was first described as a 
"glanders-like" disease among morphine addicts by Whitmore and Krishnasawami in 
Rangoon, Burma in 1911 (Whitmore et al., 1912; Whitmore, 1913). The name 
melioidosis is taken from the Greek word 'melis' meaning distemper of asses and 'eidos' 
meaning resembling glanders (Stanton et al., 1921).  
1.2 Prevalence and epidemiology 
Melioidosis is endemic in South-East Asia and Northern Australia, and in 
intertropical zones of Africa, the Indian subcontinent and South America (Leelarasamee, 
1989), but may occur anywhere between 20 degrees north and south latitudes of the 
equator. The disease is an important cause of community-acquired sepsis in Southeast 
Asia (including Thailand, Singapore, Malaysia, Vietnam, Cambodia, Laos, and 
Myanmar) and Northern Australia (White, 2003; Leelarasamee, 2004; So, 1986). There 
are some cases reported in other parts of the world such as Central America, the 
Caribbean, China, Taiwan, Africa, France, the Middle East and South Asian countries 
(Miralles et al., 2004; Christenson et al., 2003; Dance, 2000; Dance, 2002; John et al., 
1996; Leelarasamee et al., 1989). In Thailand, 2000 to 3000 new cases are diagnosed 
every year (Leelarasamee et al., 1989), and seroconversion were found in about 80% of 
children by the age of 4 years old (Kanaphun, 1993). In Malaysia, reported 
seroprevalence in healthy individuals is 17-22% in farmer (mainly rice farmers) 
(Vadivellu et al., 1995). In North Australia 0.6 to 16% of children have evidence of 
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exposure to B. pseudomallei (Currie et al., 2000). Several cases of patients with 
melioidosis who have immigrated into Europe have been reported and the disease has 
been increasingly recognized in returning travellers to Europe from endemic areas 
(Dance et al., 1999). The geographic area of the prevalence of the organism is bound to 
increase as awareness of the disease increases. 
Melioidosis is a zoonotic disease affecting horses, sheep, goats, pigs, lambs, 
cows, and other animals, as well as humans (Dance, 1991; Sprague, 2004).  The causative 
agent Burkholderia pseudomallei, is a free-living Gram-negative facultative anaerobic 
bacillus found in the region of endemicity. As a facultative environmental saprophyte, B. 
pseudomallei can be easily isolated from wet soils, rice paddies and stagnant waters in 
the tropical and subtropical regions (Dance, 2000). It is also present in rubber plantations, 
cleared fields, cultivated and irrigated agricultural sites as well as drains and ditches. It is 
believed that these habitats are the primary reservoir from which the susceptible host 
acquires infections in the regions of endemicity (Leelarasammee, 1989; Hirst et al., 
1992). Thus, there is a high rate of infection in communities that have frequent contact 
with soil and surface water (Dance, 1991; Hirst et al., 1992). Although B. pseudomallei is 
a natural inhabitant of soil and water in the tropics and subtropics, it was also found to be 
able to adapt and survive in hostile environmental conditions, including prolonged 
nutrient deficiency (Wuthiekanun et al., 1995), in antiseptic and detergent solutions (Gal 
et al., 2004), acidic environments (pH 4.5 for up to 70 days) (Dejsirilert et al., 1991), and 
a wide temperature range (24oC to 32oC), and dehydration (soil water content of less than 
10% for up to 70 days) (Tong et al., 1996; Chen et al., 2003). It is possible that harsh 
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environment conditions may confer a selective advantage for the growth of B. 
pseudomallei over other microbes (Cheng and Currie, 2005).   
1.3 Melioidosis in Singapore 
In Singapore, melioidosis was made administratively notifiable in October 1989. 
Between 1989 and 1996, a total of 372 cases were reported, giving a mean annual 
incidence rate of 1.7 per 100,000 population (Heng et al., 1998). The average annual 
number of cases was the highest in 1998, with 114 cases, giving an overall incidence rate 
of 3.6 per 100,000 population (Melioidosis in Singapore 1998, Epidemiological News 
Bulletin). This could be in part due to a greater clinical awareness among medical 
practitioners. Almost all cases reported had some underlying medical conditions, of 
which half the cases (51.8 %) were diabetic. The case-fatality rate has been reduced from 
60 % in 1989 to 17 % in 1998 (Melioidosis in Singapore 1998, Epidemiological News 
Bulletin). There was an average of 60 cases reported from 1995-2004.  The annual 
incidence of melioidosis in 2002 and 2003 was 0.84 per 100,000 and 0.96 per 100,000 
population, respectively. There were 84 cases reported between January to September in 
2004, with mortality of 32.1 %, which could be attributed to heavy rainfalls and flooding 
(Orellana, 2004). Overall, there were 96 indigenous cases of laboratory confirmed 
melioidosis in 2004. There were 84 % of cases with co-morbid medical conditions, with 
diabetes mellitus was the most common (63.5 %), followed by pneumonia (58.3 %), 
hypertension (30.2 %) and renal failure (24.0 %). The overall case-fatality rate was 26 %, 
with higher mortality rates among those with underlying medical conditions (30.8 %) and 
those with septicemia (57.3 %) (Communicable Disease Surveillance in Singapore 2004). 
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1.4 Modes of transmission  
The infection caused by B pseudomallei is thought to occur by ingestion, 
inhalation of infectious particles, or by the contact of wounds or damaged skin surface 
with contaminated soil or water (Leelarasamee et al., 1989; Dejsirilert et al., 1988; Brett 
et al., 2000). The evidence for other routes of infection such as person-to-person, and 
vector transmission is relatively weak. In northeast Thailand, researchers could only 
identify penetrating injury in 5.2 % of cases and near drowning in 0.5 % of cases, thus 
leaving 94 % non-specific exposure incidents (Suputtamongkol et al., 1992). In Australia, 
it has been identified penetrating injuries in 30% of cases and intense exposure to mud 
from heavy rain in a further 19 %, but specific exposure was still unknown in 50 % of 
cases (Currie et al., 1993). It was assumed that the majority of cases were actually 
infected by inoculation. However, ingestion and inhalation were highly possible. The 
frequency of this infection varies greatly with time. It becomes particularly prevalent 
during periods of high rainfall, when it is thought that the organism is being brought up 
from the soil to the surface by the rising water, temporarily creating a more widespread 
distribution (Thomas et al., 1979; Hirst et al., 1992; Strauss et al., 1969). The strong 
correlation of heavy rainfall and winds with sepsis and pneumonia during monsoonal 
season suggests that environmental conditions may increase the incidence of infection 
due to higher exposure through inhalation rather than inoculation (Munckhof et al., 2001; 
Currie et al., 2003). 
1.5 Clinical Manifestations 
B. pseudomallei can cause infection in any organ, although pathology occurs 
mainly in the lung, spleen and liver (Piggott et al., 1970; Wong et al., 1995). The 
 6
infection in humans shows diverse clinical presentations, ranging from asymptomatic 
state manifested by seroconversion, clinical apparent infection ranging from acute 
pneumonia to chronic pneumonia, localized infection involving one organ to 
disseminated septicemic disease involving multiple organs, and even to septic shock 
(Leelarasamee et al., 2004). Acute septicaemia could have a case fatality rate over 90 % 
if untreated (Leelarasamee et al., 1989).  Severe septicemic melioidosis is usually 
associated with underlying diseases such as diabetes and chronic renal failure, although it 
sometimes occurs in previously healthy individuals (Brett et al., 2000).  In Northeast 
Thailand where the disease is endemic, overall mortality of infected individuals is 51% 
(White, 2003).  In the acute form of the disease, death normally occurs within 24-48 h 
due to septic shock. 
   After infection, B. pseudomallei may remain dormant, becoming active only 
after months, years or decades when the host is immunocompromised. There had been 
two cases of recrudescent melioidosis following a primary exposure of 18 and 26 years 
ago (Koponen 1991, Mays 1975).  Recently, a case of reactivated melioidosis in a World 
War II veteran 62 years after environmental exposure was reported. The reactivation was 
likely triggered by trauma from a dog bite (Ngauy et al., 2005).  The factors that provoke 
the reactivation of latent infection probably are environmental variables, stress and 
immunity status (Johnson et al., 1990; Thummakul et al., 1999). The immuno-
compromised patients present with melioidosis septicaemia and their clinical features are 
similar to other Gram-negative septicemias and its prognosis is poor. Quoted mortality 
ranges from 40 % to 75 % despite rational use of anti-microbial therapy (Chaowagul et 
al., 1989).   
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1.6 Diagnosis 
Melioidosis has been called the “Great Mimicker” due to the broad spectrum of 
clinical signs and symptoms involved. This made the accurate diagnosis of acute or 
chronic melioidosis challenging. Melioidosis should be suspected in any severely ill 
febrile patient with an underlying predisposing condition who lives in, or has traveled 
from, an endemic area (White, 2003). In regions of endemicity, melioidosis should be 
considered in the differential diagnosis of any Pyrexia of Unknown Origin (PUO), acute 
respiratory distress syndrome (ARDS) and acute septicaemia (Raja et al., 2005). Clinical 
presentations of Melioidosis may include pneumonia, acute suppurative lesions, chronic 
granulomatous lesions, septic arthritis, osteomyelitis, epididymorchitis and mycotic 
aneurysm as well as radiological pattern of tuberculosis with characteristic nodular 
lesions visible on the chest X-ray but not supplemented with Mycobacterium tuberculosis 
positive sputum culture (Raja et al., 2005). Patients with diabetes usually develop 
leukocytosis, high blood glucose and glycosylated haemoglobin in the blood, and 
elevated urea and creatinine (Puthucheary, 2002). Accurate diagnosis is important for 
effective patient management. During early phase of infection, C-reactive protein (CRP) 
may be elevated due to inflammatory response; however, under normal CRP levels, 
melioidosis should not be ruled out (Cheng et al., 2004).  
1.6.1 Identification of B. pseudomallei  
Isolation of B. pseudomallei by culture from a clinical specimen (blood, urine, 
sputum, skin lesions and swab samples from throat) is the gold standard of diagnosis 
(Anuntagool et al., 1993). A few simple tests such as oxidase test, bipolar Gram staining, 
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metallic sheen colonies on selective media and resistance to aminoglycosides can be 
employed to identify B. pseudomallei in the endemic areas (Lowe et al., 2002). 
Conventional biochemical tests and API20 NE substrate-utilization test panel kit can also 
be used for identification of B. pseudomallei. However crossreaction with other species 
(such as Chromobacterium violaceum)  may occur (Inglis et al., 1998). 
1.6.2 Serological tests 
Serological tests can serve as supplementary diagnostic test in the absence of 
isolation of B. pseudomallei in the specimen.  Latex agglutination test using monoclonal 
antibody can help in quick identification of B. pseudomallei. Indirect haemagglutination 
(IHA) test is simple to perform as it detects the antibody against B. pseudomallei that 
appears in the blood within 1-2 weeks after the infection. However, interpretations may 
be difficult due to false positive, false negative or low antibody titre that does not persist 
after infection subsides. There is potential problem for the use of IHA in endemic 
regions, particularly in Thailand, where there is a high percentage of individuals with 
seroconversion due to subclinical exposure of B. pseudomallei or B. thailandensis (a 
closely related avirulent strain) early in life (Cheng and Currie, 2005). Enzyme linked 
immunosorbent assay (ELISA) test detects Burkholderia pseudomallei specific IgG and 
IgM antibodies in the serum specimens. It is more convincing in terms of sensitivity and 
specificity for antibody detection as it reflects an active disease process (Ashdown et al., 
1989). The indirect ELISA is recommended as a diagnostic serological test as it is 
relatively easier to perform. Another assay for rapid and highly sensitive diagnosis is the 
immunoflourorescent antibody assay. An indirect ELISA using truncated flagellin  as 
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antigen was recently reported to have achieved 93.8 % sensitivity, and 96.3 % specificity 
(Chen et al., 2003). 
1.6.3 Molecular identification techniques  
Molecular biology techniques such as polymerase chain reaction (PCR), dot 
immunoassay, pulsed field gel electrophoresis (PFGE), restricted fragmentation length 
polymorphism (RFLP) and random amplification of particle of deoxyribonulease 
(RAPD) can be used for diagnosis. These are the preferred techniques due to their high 
sensitivity, specificity, simplicity and speed (Raja et al., 2005).  
1.7 Management and treatment 
The acute form of melioidosis often leads to high mortality and morbidity rates 
despite long-term treatment with antibiotics.  This is partly due to the intrinsic resistance 
of B. pseudomallei to a variety of antibiotics including β-lactams, aminoglycosides, 
macrolides and polymyxins (Eickhoff et al., 1970). The clinical isolates of B. 
pseudomallei show resistance to a variety of antimicrobial agents including penicillins, 
first- and second-generation cephalosporins and many of the aminoglycosides (Dance et 
al., 1988; Leelarasamee et al., 1989; Godfrey et al., 1991). The resistance of B. 
pseudomallei to multidrug macrolide and aminoglycoside antibiotics is mediated by 
multidrug efflux pump (Moore et al., 1999). Mutations within the conserved motifs of the 
beta-lactamase enzyme also account for the resistance patterns (Tribuddharate et al., 
2003). Rational use of antimicrobials for treatment has significantly reduced the 
mortality. Treatment of severe melioidosis should include a combination of 
cefoperazone-sulbactam plus co-trimoxazole or ceftazidime plus co-trimoxazole 
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(Chetchotisakd et al., 2001). A high-dose intravenous ceftazidime regimen was shown to 
be superior to the conventional four-drug regimen (chloramphenicol, doxycycline, and 
trimethoprim-sulfamethoxazole) (Chaowagul, 2000). Despite treatment with high-dose 
celftazidime, the mortality rate of severe melioidosis remained as high as 40 % (Angus et 
al., 2000). The average time between discharge from hospital and relapse is of 21 weeks. 
Therefore, treated patients require long-term follow up, as B. pseudomallei remains latent 
for many years in the body (Mays et al., 1975; Ngauy et al., 2005). For maintenance 
therapy, Co-Amoxyclav is a safe and well-tolerated antimicrobial agent, although its 
efficacy may not be as good as co-cholamphenicol, trimoxazole and doxycycline. The 
recommended duration for maintenance therapy is of 12 to 20 weeks (Rajchanuvong et 
al., 1995; Chetchotisakd et al., 2001). Oral treatment using the four-drug regimen was 
given over 20 weeks for maintenance therapy, with chloramphenicol given only for the 
first 8 weeks. Despite this long antibiotic course, the rate of relapse is about 10 %, which 
rises to nearly 30 % if antibiotic treatment reduced to 8 weeks or less (Suputtamongkol et 
al., 1991; Chaowagul et al., 1993; Rajchanuvong et al., 1995; Chaowagul et al., 1999; 
Chaowagul, 2000; Currie et al., 2000). Risk of relapse is related to adherence to treatment 
and the initial extent of disease, but not to the underlying condition (Chaowagul et al., 
1993). B. pseudomallei strains resistant to chloramphenicol, ceftazidime and polymyxin 
B are known to emerge during maintenance therapy. The chloramphenicol-and 
ceftazidime-resistant B. pseudomallei strains were reported to be fully virulent and 
frequently showed cross-resistance to other anti-microbials such as tetracycline, 
sulfamethoxazole, trimethoprim, and ciprofloxacin (Dance et al., 1989). In addition, 
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when the infection turns into the latent stage, drugs would be less efficient because 
bacteria are dormant (Kanai et al., 1988).   
1.8 Bacterial pathogenesis  
1.8.1 Gene and Genome  
 Burkholderia pseudomallei was previously classified under the genus 
“Pseudomonas”. Based on the 16S rRNA sequences, DNA-DNA homology values, 
cellular lipid and fatty acid composition, and phenotypic characteristics, it has been 
transferred to the new genus Burkholderia since 1992 (Yabuuchi et al., 1992). The entire 
genome of B. pseudomallei has been sequenced by The Wellcome Trust Sanger Institute 
in collaboration with institutes from Thailand, Australia and the US. The complete 
genome consists of two chromosomes of 4.07 megabase pairs and 3.17 megabase pairs, 
showing significant functional partitioning of genes between the two chromosomes. The 
large chromosome 1 encodes many of the core functions associated with central 
metabolism and cell growth, whereas the small chromosome carries more accessory 
functions associated with adaptation and survival in different niches (Holden et al., 2004) 
1.8.2 Virulence factors  
The virulence factors of B. pseudomallei include various endotoxins, exotoxins, 
proteases, malleobactins, flagella, antiphagocytic capsule, fimbriae, and pili (Smith et al., 
1987; Jones et al., 1996; Cheng and Currie 2005). These are an impressive array of both 
secreted and cell-associated antigens.  In order to invade various hosts, B. pseudomallei 
adapts by  producing virulence factors such as proteases (Sexton et al., 1994; Lee and 
Liu, 2000), phospholipase C (Korbsrisate et al., 1999), and hemolysin, lecithinase, and 
lipase (Ashdown and Koehler, 1990). These antigens are probably secreted via the 
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general secretory pathway (DeShazer et al., 1999) and their exact roles in pathogenesis 
are unclear. Transposon mutations in the general secretory pathway, resulting in a failure 
to secrete protease, lipase, or lecithinase, do not appear to result in an attenuation of 
virulence in an animal model (Brett and Woods, 2000). It had been shown that a 
siderophore, malleobactin, which is a prerequisite for the successful establishment and 
maintenance of infections, is produced by B. pseudomallei and is efficient at acquiring 
iron at acidic pH (Yang et al., 1993). Besides, B. pseudomallei can form biofilm that 
allows the bacteria to dramatically increase their resistance to antibiotics (Song et al., 
2003). However, the mechanisms through which the changes in environmental factors 
alter the virulence of the bacteria remain to be elucidated. 
As for cell-associated antigens, capsular polysaccharides enable bacteria to evade 
host defense mechanisms by inhibiting complement activation and phagocytic mediated 
killing (Smith et al., 1987; Pruksachartvuthi et al., 1990).  The type II O antigenic–
polysaccharide (O-PS II) of B. pseudomallei lipopolysaccharide (LPS) has been 
demonstrated to be essential for its virulence (DeShazer et al., 1998). The capsule was 
found to inhibit deposition of complement factor C3b, important in the alternative 
pathway. This allows the bacteria to resist complement mediated killing and reduced their 
ability to be opsonized (Reckseidler-Zenteno et al, 2005). In recent studies, flagella 
which confer motility have been shown to be the important virulence determinant in the 
in vitro and in vivo infection (Chua et al., 2003). Thus, purified flagellin may serve as a 
protective immunogen against B. pseudomallei infections (Brett et al., 1994; DeShazer et 
al., 1997). 
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B. pseudomallei can invade many eukaryotic cell lines. In both phagocytic and 
non-phagocytic cell lines, it can escape from the specialised endocytic vacuoles into the 
cytoplasm to form actin-associated membrane protrusion that is thought to contribute to 
cell-to-cell spreading in infected hosts (Jone et al., 1996; Kespichayawattana et al., 2000; 
Stevens et al., 2002; Breitbach et al., 2003). Capsule and a bsa type III secretion system 
facilitate B. pseudomallei to survive, escape from endocytic vesicles, facilitate bacterial 
invasion of epithelial cells and intracellular survival (Stevens et al., 2004; Ghosh, 2004). 
The uptake of B. pseudomallei by several cell lines in culture leads to induction of cell 
fusion and formation of a multinucleated large cells mediated by a TTSS protein, BipB 
(Harley et al., 1998; Suparak et al., 2005). Production of nitric oxide in macrophages can 
be bactericidal and  failure of infected cells to successfully control the growth and 
subsequent survival of intracellular B. pseudomallei has been attributed to the 
suppression of inducible nitric oxide synthase (iNOS) by B. pseudomallei 
(Utaisincharoen et al., 2003 ). However, both type I and type II interferons were reported 
to enhance antimicrobial activity of macrophage infected B. pseudomallei by up-
regulating iNOS (Utaisincharoen et al., 2004). It has also been showed that B. 
pseudomallei could induce a caspase-1 dependent death in macrophages and dendritic 
cells resembling oncosis which is influenced by the bsa TTSS (Sun et al., 2005). 
1.9 Animal model for melioidosis 
             In many bacterial infections, the mouse model has proven to be invaluable for 
studies of bacterial virulence factors and host-pathogen interactions. Previously, rat 
animal model made diabetic by streptozotocin injection intraperitoneally had shown that 
the diabetic rat was significantly more susceptible to B. pseudomallei septicemia than 
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control rats (Woods et al., 1993).   Subsequently, a model of B. pseudomallei infection in 
Syrian golden hamsters has proven to be useful in the studies on the pathogenesis of 
infections due to B. pseudomallei (Brett et al., 1997).  However, the diabetic rats and 
hamsters were exquisitely sensitive to B. pseudomallei, dying within two days after 
infection, which made any in vivo studies difficult (Brett et al., 1997).  A murine model 
that mimics the acute and chronic form of human systemic melioidosis has since been 
established. BALB/c mice are susceptible while C57BL/6 are relatively more resistant in 
intravenous (Leakey et al., 1998, Hoppe et al., 1999) and intranasal (Liu et al., 2002) 
routes of infection. BALB/c mice succumbed a few days after infection, reflecting a 
failure of host innate immune response to contain the infection (Leakey 1998, Hoppe 
1999).  They produced higher levels of proinflammatory cytokines such as TNF-α, IL-1β 
and IFN-γ than C57BL/6 mice at one to two days after infection (Ulett et al., 2000; Liu et 
al., 2002).  Electron microscopic investigation of the spleen clearly demonstrated 
intracellular replication within membrane-bound phagosomes. Electron micrographs of 
the liver provided evidence that B. pseudomallei containing phagosomes in hepatocytes 
fused with lysosomes, leading to degradation of bacteria (Hoppe et al., 1999). The 
bacterial counts in C57BL/6 mice were decreased 12 h after infection in comparison to 
BALB/c mice which suggests an innate immune mechanism against B. pseudomallei in 
the early phase of infection contributing to the relatively resistant phenotype of C57BL/6 
to the infection. Studies using animal models suggest that the course of infection is highly 
dependent on the infective dose, the route of infection and the virulence of the infecting 
strain (Ulett et al., 2000; Liu et al., 2002). 
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1.10 Role of cytokines in immunity  
Cytokines are a group of low-molecular-weight immunomodulating proteins 
secreted by leukocytes and a variety of non-immune cells in the body in response to a 
number of stimuli. They help to regulate the hematopoiesis, inflammatory response, and 
both innate and specific immunity. These proteins act as autocrines, paracrines or 
endrocrines, through binding to specific receptors on the membrane of target cells, 
triggering signal transduction pathways that ultimately alter gene expression in the target 
cells. Hence, they play important roles in host defense during infections. In innate 
immunity, the effector cytokines are mostly produced by mononuclear phagocytes and 
are therefore sometimes called monokines. Monokines elicit neutrophil-rich 
inflammatory reactions that serve to contain and eradicate microbial infections (Abbas et 
al., 1997). However, the more inclusive term cytokine is still preferred. Another major 
source of cytokines is T lymphocytes; they produce cytokines that serve primarily to 
regulate the growth and differentiation of various lymphocyte populations during 
activation phase of immune response (Abbas et al., 1997). Other cell-derived cytokines 
function to activate and regulate inflammatory cells such as mononuclear phagocytes, 
dentritic cells, neutrophils and eosinophils. Many cytokines are made by certain 
populations of leukocytes and act on other leukocytes, hence known as interleukins (IL). 
Another group of cytokines affects chemotasis and other aspects of leukocytes 
behaviours, they are known as chemokines.  
Cytokine responses following intracellular infection can be classified into Th1 or 
Th2 type based on the activity of CD4+ T helper cells and the cytokine profiles induced. 
Th1 cytokines include IFN-γ, IL-2 and TNF-α, among these cytokines IFN-γ is the chief 
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cytokine responsible for their proinflammaotry effects. IFN-γ activates the function of 
macrophages, it enhances phagocytosis, promotes microbicidal activity against 
intracellular microbes (reviewed by Spellberg and Edward, 2001). It also upregulates the 
level of both class I and class II major histocompatibility complex (MHC) molecules, 
thereby stimulating antigen presentation to T cells. Besides that, IFN-γ increases 
secretion of cytokine such as IL-12 by macrophages and dendritic cells, and up-regulates 
the IL-12 receptor on T cells, leading to increase differentiation of naïve T cells to Th1 
cells, thus enhancing the cell-mediated immune response (Spellberg and Edward, 2001). 
Hence, Th1 response is associated to resistance to intracellular pathogens. Th2 cells on 
the other hand, stimulate high titers of antibody and suppress macrophage activation. Th2 
cytokines include IL-4, IL5, IL-6, IL-10 and IL-13 (Richard et al., 2000). The key 
cytokine IL-4 involves in activation of B cell proliferation, antibody production and class 
switching to IgG1, which does not fix complement. IL-4 also increases the antibody class 
switching from IgM to IgE. This effect is enhanced by IL-5. Th1 and Th2 cells cross 
regulate one another (Spellberg and Edward, 2001). The IFN-γ secreted by Th1 cells 
directly suppresses IL-4 secretion and thus inhibits differentiation of naïve T cells (or 
Th0) cells into Th2 cells. Conversely, IL-4 and IL-10 inhibit the secretion of IL-12 and 
IFN-γ, blocking the ability of Th0 cells to polarize intro Th1 cells. Th2 cytokines inhibit 
phagocytosis and intracellular killing, and suppress inflammatory cytokine production 
(Spellberg and Edward, 2001). Therefore, Th2 polarization is linked to susceptibility to 
intracellular pathogen infection. In addition, Th1- and Th2-type immune responses are 
associated with different patterns of antibody isotypes and subclasses. The complement-
fixing antibodies of the murine IgG2a and IgG3 subclasses are associated with Th1-type 
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IFN-γ driven immune responses while noncomplement-fixing IgG1 are associated with 
Th2-type responses and IL-4 production (Mosmann and Coffman, 1989; Finkelman et al., 
1990). 
Studies on intracellular pathogens have demonstrated that IFN-γ, TNF-α and 
several interleukins (such as IL-12) play important role in innate host resistance during 
infection. Early cytokines regulate the phagocytic and antimicrobial activity of 
macrophages, also affect the interactions between macrophages and lymphocytes, and 
ultimately influence the differentiation pathway of CD4+ T helper cells (Mosmann et al., 
1986; Schaarton et al., 1993), and they have been shown to be important for effective 
anti-B. pseudomallei activity (Ulett et al., 1998).  In addition to increasing antimicrobial 
activity in macrophages, proinflammatory cytokines including IFN-γ, TNF-α, IL-1β and 
IL-6 are also important mediators in the processes of endotoxic shock (Car et al., 1994; 
Ulrich et al., 1991; Takasuka et al., 1991; Havell et al., 1992). In murine model of 
melioidosis, IFN-γ was shown to play an obligatory role (Santanirand et al,. 1999). 
Administration of neutralizing antibodies against IFN-γ lowered the LD50 dose from 
>5x105 to about 2 CFU and associated with increased bacterial burdens in liver and 
spleen (Santanirand et al,. 1999). However, in patients with severe melioidosis elevated 
levels of TNF-α (Simpson et al., 2000), IFN-γ (Brown et al., 1991; Lauw et al., 1999) 
and IFN-γ induced chemokines IP-10 and MIG (Lauw et al., 2000) were observed to 
correlate with severe disease. Therefore, regulation of proinflammatory cytokines 
production during the innate response is critical in maintaining a balance between 
antimicrobial activity and the degree of host immunopathology. 
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BALB/c mice are genetically prone to Th2 immune responses, whereas C57BL/6 
mice are prone to Th1 immunity. The genetic mechanisms of these tendencies are 
probably due to the fact that BALB/c mice have a defect in the normal induction of IL-
12, and perhaps also contributed by a tendency for early hyperporduction of IL-4 (Alleva 
et al., 1998; Himmerlrich et al., 1998). The innate resistance of C57BL/6 mice to several 
intracellular pathogens has been found to be contributed by increased activity of Th1-type 
cells and induction of a strong Th1-type cytokine response (Scharton et al., 1993; 
Autenrieth et al., 1994; Brett et al., 1986; Heinzel et al., 1998). The innate susceptibility 
of BALB/c mice to numerous intracellular pathogens on the other hand, has been linked 
to weak IFN-γ response and strong Th2-type cytokine response. This is because Th1 
cytokines tend to stimulate cell-mediated immunity, which confer resistance to 
intracellular pathogens. Cytokines produced in the Th2-type responses stimulate a strong 
humoral immunity, which is thought to be important for resistance to extracelllular 
pathogens (Hsieh et al., 1993; Autenrieth et al., 1994).  
 
1.11 Objectives of present study 
  In this study, a virulent strain of B. pseudomallei was used for intranasal infection of 
BALB/c and C57BL/6 mice to mimic the route of infection through inhalation. The 
overall objective of this project is to identify the factors that could contribute to 
differential susceptibility to B. pseudomallei using the BALB/c-C57BL/6 intranasal 
infection model. The specific aims are: 
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1. To compare and characterize the innate host response to murine mucosal infection 
model through determining the LD50, bacterial loads, pathology and early 
cytokine responses. 
2. To identify the types of humoral immune responses in susceptible BALB/c mice 
before and after immunization with recombinant flagellin (r-FliC), and to examine 
whether immunization can confer protection against live B. pseudomallei 
challenge. 
3. To identify the types of humoral immune responses before and after infection of 
C57BL/6 mice with low dose infection, and to study the protective immune 
responses elicited in low dose immunized mice against high dose B. pseudomallei 
challenge. 
4. To characterize and compare the innate cytokine responses in the splenocytes of 
the differential susceptible mouse strain in vitro and identify the cell types 
producing the cytokines upon treatment with B. pseudomallei. 
 
The knowledge gained through this study could help in designing immunotherapies or 
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2.1 INTRODUCTION  
 
 The disease caused by B. pseudomallei varies from asymptomatic state, benign 
pneumonitis, acute or chronic pneumonia, to fulminant septicemias (Chaowagul et al., 
1989). In most cases, infection is believed to occur through subcutaneous inoculation of 
contaminated soil and water, although ingestion or inhalation of contaminated aerosols is 
also highly possible (Hirst et al., 1992; Leelarasamee et al., 1989).  As melioidosis 
presents such varied clinical presentations, it is possible that the route of infection is one 
of several factors that influences disease outcome.    
 
                In any study on infectious disease, a suitable animal model is the most critical 
and invaluable tool through which the pathogenesis and the mechanisms of host 
resistance can be identified. Recently, the murine model for the acute and chronic forms 
of human melioidosis has been established (Leakey et al., 1998; Hoppe et al., 1999). It 
was demonstrated that BALB/c mice were highly susceptible to intravenous infection 
with virulent B. pseudomallei, while C57BL/6 mice were relatively resistant.  Following 
intravenous infection with low dose virulent B. pseudomallei (37 CFU), substantial 
bacterial growth was found in the liver and spleen of BALB/c mice with visible 
abscesses, followed by septicemia which lead to death of infected mice within 72 to 96 h. 
In contrast, C57BL/6 mice did not develop septicemia, although they eventually 
succumbed to the infection 2-6 weeks later due to bacterial growth in liver and spleen, 
suggesting an incomplete resistance to the bacteria (Leakey et al., 1998). This differential 
susceptibility animal model using BALB/c and C57BL/6 mice has since then become the 
most commonly used model for elucidating immunopathogensis of melioidosis (Hoppe et 
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al., 1999; Ulett et al., 1998; Ulett et al., 2000; Barnes et al., 2001; Jeddeloh et al., 2003; 
Lui et al., 2002). 
             The intraperitoneal and intravenous routes of infections used in animal models 
are thought to mimic systemic melioidosis.  However, the first exposure to many 
microorganisms is often through the mucosal surfaces in the nasal passages and the gut.  
The diverse clinical presentations are thought to be contributed in part by the difference 
in the routes of infection, as it can lead to different disease outcomes due to differences in 
the local immune environment. In this study, the outcome of intranasal infection of 
BALB/c and C57BL/6 mice with virulent B. pseudomallei to mimic natural infection 
through inhalation was elucidated and the murine model of differential susceptibility 
validated.  The establishment of an intranasal infection model with differential outcomes 
would allow us to investigate the factors that could potentially contribute to host 
resistance and to our understanding of mucosal immunity. Cytokine response, particularly 
the hyperproduction of IFN-γ was studied to examine its role during B. pseudomallei 
infection. Such knowledge is important as the identification of factors contributing to 
protective immunity in the resistant host could inspire strategic design of vaccines or 
prophylaxis for the disease.  
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2.2 MATERIALS AND METHODS 
2.2.1 Animals 
Female 5-6 week old inbred C57BL/6J and BALB/c mice were purchased from 
the Laboratory Animals Center of the National University of Singapore. The inbred 
BALB/c and C57BL/6J mice were originally imported from Animal Research Center, 
Western Australia. The mice were originally were housed in polypropylene cages with a 
bedding of wood shavings and were fed on a diet of commercial pellets (Glenforrest 
Stock Feeders, Perth) and portable water ad libitum.  The cages were maintained in an 
isolated animal room, with a class II biological safety cabinet.  All experimental 
procedures on animals and infection were approved by the Institututional Animal Care 
and Use Committee (IACUC) of National University of Singapore. 
2.2.2 Bacteria 
Virulent Burkholderia pseudomallei strain KHW used in this study is a local 
clinical isolate from a fatal case of melioidosis in Singapore. The isolate was identified as 
B. pseudomallei based on colonial morphology, API20 NE tests (BioMerieux, Marcy 
I’Etoile, France), and 16S RNA sequence.  For inoculation into mice, bacteria were 
cultured on Trypticase soy agar (TSA) (Difco Laboratories, Detroit, Mich.) for 24 h at 37 
°C, colonies were  picked and suspended in sterile phosphate-buffered saline (PBS), and 
the bacterial suspension was adjusted to a density equivalent to that of a 1.0 McFarland 
nephelometer standard (approximately 1.5x108 CFU/ml). The suspension was then 
diluted to the appropriate concentration in PBS for inoculation, and aliquots were plated 
on TSA in duplicates to determine the actual number of bacteria inoculated.   
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2.2.3 LD50 determination 
Mice were divided into groups of six or seven and each group was inoculated with 
a different dose (Table 1). The doses reported reflect the actual dose of the inoculum as 
determined by colony counts on TSA plates. After being anesthetized with a combination 
of Hypnorm and midazolam, the mice were inoculated intranasally, through one nostril 
with a yellow pipette tip, with the appropriate dose of B. pseudomallei in 20 μl of PBS. 
Mortality was scored over 10 days. 
2.2.4 Infection of mice and preparation of organs 
After anaesthetizing with a combination of hypnorm and midazolam, the mice 
were inoculated intranasally, through one nostril with a yellow pipette tip, with B. 
pseudomallei in 20 μl of PBS. Control mice were inoculated with PBS only. At 24, 48, 
72, 96 or 120 hours after infection, infected and control mice were euthanized.  The 
lungs, livers and spleens were aseptically removed and placed in 3 ml of ice-cold medium 
separately and immediately homogenized on ice.   A small aliquot was removed for serial 
dilution in PBS and plated on Ashdown agar (Ashdown, 1979) in duplicate for each 
dilution.  The colonies on plates were counted after 24-48 h of incubation at 37°C and the 
bacterial load per organ calculated from the average count taken from plates of 
appropriate dilutions giving countable colonies. The rest of the homogenates were 
centrifuged at 4 °C and resuspended in Trizol reagent for immediate RNA isolation or 




2.2.5 RNA isolation and reverse transcription-polymerase chain Reaction (RT-
PCR).  
 
Total RNA was extracted using Trizol reagent (Gibco-BRL, Grand Island, New 
York) according to manufacturer’s instructions.  RNA was resuspended in diethyl 
pyrocarbonate-treated water and quantity determined using spectrophotometer at 260 nm. 
Five micrograms of RNA was used for reverse transcription in a final mixture of 0.16 μM 
oligo dT, 0.25 mM dNTPs, 20 U M-MuLV reverse transcriptase (Biotools-
Biotechnological and Medical Laboratories, Spain), and 12 U  RNasin  (Promega, 
Madison, Wisconsin).  The reaction was performed for 1 h at 37 oC and the resulting 
cDNA readjusted to 150 μl with Tris-EDTA buffer.  The final PCR mixture contained 5 
μl cDNA, 1x PCR buffer (Biotools), 0.25 mM dNTPs, 0.6 U Taq DNA polymerase 
(Biotools) and 0.4 μM sense and antisense primers.  The thermal cycling parameters were 
as follows: 95 oC for 5 min, followed by 30 cycles of denaturation at 95 oC for 1 min, 
annealing at 1-2 oC below Tm of primers for 1 min, and extension at 72 oC for 2 min.  
PCR was performed using cytokine specific primers for IFN-γ (forward primer: 5’-ACT 
GCC ACG GCA CAG TC-3’; reverse primer: 5’-CCG CTT CCT GAG GCT G-3’), and 
Glyseraldehyde-3-phosphate dehydrogenase (GAPDH, forward primer: 5’-TTC ACC 
ACC ATG GAG AAG GC-3’; reverse primer: 5’-GGC ATG GAC TGT GGT CAT GA-
3’) was used as internal control. All PCR reactions were performed in an automated DNA 
thermal cycler (MJ Research, Watertown, Massachusetts).  PCR products were size 
fractionated through 1 % agarose gel containing ethidium bromide (0.1 mg/ml) and 
visualized with ultra-violet (UV) light. The PCR reactions for a series of 10-fold dilutions 
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of selected cDNA templates were carried out to ensure no saturation at the conditions 
used.  
2.2.6 Determination of Cytokine Concentration by ELISA 
Naïve mice were inoculated intranasally with either low dose (50 CFU/20 μl) or 
high dose (5,000 CFU/20 μl) of bacteria as indicated, control mice where inoculated with 
PBS.  At various time points after infection, mice were anesthetized and blood was 
collected by cardiac puncture from 3 mice of each mouse strain.  Blood was allowed to 
clot overnight at 4oC and centrifuged to obtain the serum.  Samples were assayed for 
IFNγ with ELISA kits (Bender MedSystem, Vienna, Austria) according to 
manufacturer’s instruction. The optical densities were measured at wavelengths of 450 
nm and 570 nm using a SPECTRAmax190 spectrophotometer (Beckman Coulter, 
California, USA). Samples from three uninfected BALB/c and three C57BL/6 mice were 
also tested as negative controls.  The ELISAs were performed in duplicates.  The 
detection limit for this assay is 15.6  pg/ml for IFN-γ. 
 
2.2.7 Flow cytometric analysis.   
Antibodies used for cell surface staining were purchased from BD Pharmingen 
(San Diego, CA) unless otherwise stated: anti-Ly-6G-PE (1A8, rat IgG2a), anti-CD11b-
bitoin (M1/70, rat IgG2b). At 48 hr post-inoculation, the control and infected mice were 
sacrificed and spleens removed. The single cell suspension of splenocytes was obtained 
by smashing with plunger of a 5 ml syringe, passing through 19G needle, and filtering 
through a 60 μM filter. The cells were centrifuged at 1400 rpm. After removing 
supernatant, red blood cells (RBCs) were lysed with 4.5 ml of sterile distilled water for a 
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~10 seconds and 0.5 ml of 10xPBS was then added to reconstitute to 1xPBS to prevent 
lysis of the leukocytes. The cells were then centrifuged and debris was removed. 
Splenocytes were adjusted to 1x106 cells and stained with cell surface specific antibodies 
or isotype control antibodies for 30 min on ice. If the biotin conjugated antibodies were 
used, staining with SAV-PE/SAV-FITC or secondary antibody was performed for 15 min 
at 4°C. After washing, the cells were analyzed by FACScan flow cytometer (Becton 
Dickinson, San Jose, CA).   
 
2.2.8 Tissue Pathology 
Two mice from each group were sacrificed on 1, 2 or 4 days after infection, the 
lung, spleen and liver were fixed with 10 % paraformaldehyde-PBS buffer. Samples were 
given to Pathology Department for further processing. Briefly, the organs fixed in neutral 
buffered formalin were embedded in paraffin, sectioned at 4 µm, and stained with 
hematoxylin-eosin. This was done in collaboration with Associate Professor Chong Siew 
Meng from Department of Pathology, NUS.  
 
2.2.9 Statistical Analysis 
Statistical significance was determined by Student’s t-test or ANOVA. A p value 





2.3.1 LD50 of Burkholderia pseudomallei in BALB/c and C57BL/6 mice 
In order to understand the pathogenesis of the disease and the mechanism of host 
resistance, a murine model that mimics the acute and chronic forms of human melioidosis 
was established. It has been shown that BALB/c mice were highly susceptible to the 
infection of virulent B. pseudomallei; while C57BL/6 mice were relatively resistant 
(Leakey et al., 1998). In this study we examined the outcome of intranasal infection of 
BALB/c and C57BL/6 mice with virulent B. pseudomallei strain KHW to mimic the 
natural infection through inhalation and to determine if the murine model of differential 
susceptibility is still valid. The actual doses of bacteria inoculated were listed in Table 1. 
We found that the 10-day LD50s for the virulent B. pseudomallei strain KHW was 32 
CFU and 446 CFU for intranasal infection of BALB/c and C57BL/6 mice, respectively 
(Figure 1). Therefore, based on the LD50 values, C57BL/6 mice were around 14-fold 
more resistant to intranasal infection of B. pseudomallei than BALB/c mice. 
 
2.3.2 Bacterial loads in the infected organs 
To examine the kinetics of B. pseudomallei infection, the bacterial loads in the lungs, 
livers and spleens of infected mice were determined. During the 3-day period the bacterial 
load in BALB/c mice was significantly higher than C57BL/6 mice for all the three organs 
examined: lungs, livers and spleens (p<0.0005, p=0.001 and p<0.0005 respectively by ANOVA). 
The results show that BALB/c mice developed acute melioidosis with very high bacterial 
loads in the lungs and spleens by the second day after infection, while the livers 
contained significantly fewer bacteria (Figure 2). The infected BALB/c mice succumbed 
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to the disease within two weeks. In contrast, relatively resistant C57BL/6 mice had very 
few bacteria in all the three organs examined (Figure 2D, E and F), and mice survived for 
more than two weeks after infection. Therefore, the bacterial loads in the organs 
correlated with disease progression. It is likely that the ability to control the growth of 
bacteria at the early time points of infection is the key factor determining survival of the 
infected mice. 
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Figure 1 The 10-Day LD50 for intranasal infection of BALB/c and C57BL/6J mice 
with B. pseudomallei, strain KHW. Mice were divided into groups of six, and each 
group was inoculated with a different dose of bacteria. The doses reported reflect the 
actual dose of the inoculums as determined by colony counts on TSA plates. Mice were 
inoculated intranasally through one nostril with the appropriate dose of B. pseudomallei 




Number dead/total at 10 days after intranasal infection 
with the following respective inoculation dose: 
  LD50 
   
Dose 9 27 81 243 729 (CFU) 
BALB/c 2/6 3/7 5/6 5/6 6/6 32 
       
Dose 81 243 729 2187 6561 (CFU) 
C57BL/6 0/7 2/7 4/6 6/6 6/6 446 
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Figure 2 Bacterial loads in the infected organs. The bacterial loads in the lungs, livers and 
spleens of BALB/c and C57BL/6 mice at 24, 48 and 72 h after intranasal infection with 50 CFU 
of virulent B. pseudomallei, strain KHW. The serially diluted cell suspensions of each infected 
organ were plated onto selective Ashdown agar plates (Ashdown, 1979), and the number of 
colony forming unit (CFU) for B. pseudomallei were counted after 48 h incubation at 37 0C 
incubator. The logarithm of the number of CFU was plotted against time. Each time point on the 
graph represents one infected mouse. The control mice inoculated with PBS only were not 
represented on the graph, as no colony was found in any of the Ashdown plates. Filled symbols 
represent mice from one experiment and clear symbols represent animals from another 
experiment.  Results from the two experiments performed under the same conditions are 
superimposed. The bacterial loads were compared between BALB/c and C57BL/6 over a period 
of 3 days, and ANOVA with repeated measures was used to analyze the measurement of bacterial 
loads over the three time points.  
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2.3.3 Cytokine Responses 
To study the role of cytokines in contribution to the differential susceptibility of 
BALB/c and C57BL/6 mice, the expression of cytokines in the lung, liver and spleen 
were examined. We had previously published the cytokine profiles in the infected organs 
and the serum by RT-PCR and ELISA, respectively (Liu et al., 2002). Cytokine induction 
detected by RT-PCR and serum at early time points of post-infection was neither of Th1 
or Th2 profile. Higher proinflammatory cytokines including IL-1β, IL-6, TNF-α, and 
IFN-γ were detected in the susceptible BALB/c mice compared to C57BL/6 mice in the 
lungs, livers, spleens and sera (Liu et al., 2002). Among all the cytokines examined, 
transient hyperproduction of IFN-γ of the susceptible BALB/c mice was the most obvious 
difference between the two strains of mice.  The mRNA transcripts of cytokines generally 
peaked on day 2 following the infection and subsequently decreased in the amounts. As 
shown in Figure 3, the basal level of IFN-γ transcription was low in both uninfected 
BALB/c and C57BL/6 mice, with C57BL/6 showing slightly higher background 
expression than BALB/c mice. The expression level of mRNA transcripts for IFN-γ was 
mostly undetectable in the spleens of BALB/c mice and remained at baseline in the 
C57BL/6 mice on day 1 post infection (Figures 3A lane 1-3). There was a more obvious 
induction of IFN-γ on day 2 post infection in the BALB/c mice as compared to C57BL/6  
mice (which only had a moderate increase),  followed by a decrease on day 3(Figures 3A 





2.3.4 Kinetics of IFN-γ  response upon low dose infection  
Previously we found that susceptible BALB/c mice responded to intranasal 
infection of B. pseudomallei strain KHW with hyperproduction of serum IFN-γ two days 
after infection, but the level was drastically reduced when examined at day 4 using 
ELISA (Liu et al., 2002).  A closer examination at the kinetics of serum IFN-γ levels in 
the susceptible BALB/c and relatively resistant C57BL/6 mice showed that IFN-γ levels 
peaked at day 2 and rapidly dropped to low levels at day 3 in BALB/c mice (Figure 4).  
This transient peak correlated with the mRNA transcript levels detected by semi-
quantitative RT-PCR and was highly reproducible and specific at day 2 after infection, 
and was not seen in the C57BL/6 mice.  It thus appears that the transient hyperproduction 
of serum IFN-γ in BALB/c mice could be resulted from the increased bacterial loads 
(Figure 2) which could lead to uncontrolled inflammation, eventually leading to death. 
 
 
Figure 3 RT-PCR for IFN-γ mRNA transcripts in the spleen of BALB/c and C57BL/6 mice. 
IFN-γ gene expression in BALB/c and C57BL/6 spleens was examined during day 1, 2 and 3 
following low dose intranasal infection with B. pseudomallei. Lane M: 100bp Molecular Weight 
marker; Lane N: no template control; Lane 1-3: B. pseudomallei infected mice 24 h post-
infection; Lane 4: control mouse for 24 h post-infection; Lane 5-7: B. pseudomallei infected mice 
48 h post-infection; Lane 8: control mouse for 48 h post-infection; lane 9-11: B. pseudomallei 
infected mice 72 h post-infection; Lane 12: control mouse for 72 h post-infection. The expected 







Figure 4. The kinetics of IFN-γ response in serum after intranasal infection. BALB/c and 
C57BL/6 mice were infected intranasally with 50 CFU of virulent B. pseudomallei strain KHW. 
Three mice from each mouse strain were killed at various time points (day 0, 1, 2, 3 and 5), and 
the levelsof IFN-γ  in the serum of each animal was measured by ELISA (i). For a better 
demonstration, the same set of data was log-transformed and presented in a separate format (ii). 







2.3.5 IFN-γ response and bacterial load in the serum of C57BL/6 mice upon high 
dose infection 
To determine if this transient IFN-γ hyperproduction is associated with high 
bacterial burden or a peculiar property of BALB/c mice, we infected C57BL/6 mice with 
a high dose of bacteria. Comparisons of serum IFN-γ levels and bacterial loads were 
made between the high dose and lose dose infected C57BL/6 mice to see if there is any 
correlation between the infective dose and the host response. The results show that 
C57BL/6 mice developed septicemia when challenged with high dose of bacteria, the 
bacterial loads reached the highest point on day 2, and were at least 2-3 log scale higher 
than the low dose challenged mice (Figure 5A). The serum IFN-γ concentrations detected 
by ELISA were the highest on day-2 post-infection and correlated closely with the 
bacterial loads (Figure 5B). Furthermore, serum IFN-γ response was also transient, even 
though high IFN-γ was only detectable on day 2, which was one day after bacteria were 
detectable in the serum.  It is possible that once a threshold of bacterial burden is reached, 
IFN-γ concentration will begin to rise and when bacteria are cleared from the circulation, 
there will be a corresponding drop. We found that high dose infection (with 5,000 CFU) 
was lethal to C57BL/6 mice, leading to a disease course similar to BALB/c mice infected 
with 50 CFU, causing death within 10 days.   
 
2.3.6 Bacterial loads in organs of high dose and low dose challenged C57BL/6 mice  
Comparison of bacterial loads in the lungs, livers, spleens and brains were made 
between high dose and low dose challenged C57BL/6 mice at different time points 
(Figure 6). There was at least 2-3 log scale higher bacterial load in the high dose 
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challenged mice even as early as the 24 h after infection. These data suggest that the 
initial control of bacterial spread by the innate immune system could be the most critical 
point to prevent uncontrolled septicemic infection, as uncontrolled bacterial growth in 
both BALB/c and C57BL/6 mice could eventually lead to death. 
 
 
Figure 5 Bacterial loads and serum IFN-γ response in the C57BL/6 mice after high dose and 
low dose infection. C57BL/6J mice were challenged with either 50 CFU or 5, 000 CFU of 
virulent B. pseudomallei strain KHW, the bacterial loads in the blood (A) and the IFN-γ level in 
the serum were examined on day 1, 2 and 4 after infection (B). At each time point, three mice 
from each group were sacrificed. The serum concentration of IFN-γ  was measured by ELISA and 
the number of bacteria counted after plating the serial dilutions. Data was analysed by student’s t-
test. The bacterial loads were significantly higher in high dose infected mice on day 1 and day 2 
post-infection (p=0.03 and p=0.001, respectively). Whereas the IFN-γ levels were significantly 
higher in the high dose infected mice on day 2 post-infection only (p=0.02).  
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Figure 6 Bacterial loads in the organs of low dose and high dose infected C57BL/6 mice. 
Mice were infected with low dose or high dose of virulent strain of B. pseudomallei, and 
sacrificed at the indicated time point, smashed, and bacterial loads were obtained by plating of 
serial dilutions from the tissue suspension. Each data point represents the amount of bacteria in 
CFU obtained from one mouse. 
 
2.3.7 Pathology of infected organs 
The pathology in the infected organs was studied by Hematoxylin and Eosin (H & E) 
staining of the cross-sections of paraformaldehyde-fixed tissues.  Tissue pathology in the low 
dose infected BALB/c mice was the most obvious on day 2 onwards, with development of 
abscesses in the lung and spleen clearly seen (Figure 7A). There were infiltrations of immune 
cells in the foci of lesions. The lungs and spleens of low dose infected C57BL/6 mice did not 
show obvious pathology as compared to control tissues. However, the lungs, spleens and livers of 
high dose infected C57BL/6 showed severe pathology characteristics of abscesses and 




Figure 7 A Tissue pathology in the spleens and lungs of BALB/c mice. The tissues sections of the lung and spleen from control (1 
and 4) and low dose (2, 3, 5 and 6) B. pseudomallei infected BALB/c mice were prepared, stained with H & E and viewed under light 
microscopes. Samples showed are those obtained after day 2 of infection when the pathology became more obvious. The 






Figure 7 B Tissue pathology in the lungs and spleens of C57BL/6 mice. The tissues sections of the lung and spleen from control (7 
& 10), low dose (8 & 11) or high dose (9 & 12) B. pseudomallei infected BALB/c mice were prepared, stained with H & E and 
viewed under light microscopes. Samples showed are those obtained after day 2 of infection when the pathology became more 
obvious. The magnification is indicated in the parentheses. Abscesses and granulomas are highlighted with arrows. Representative 
pictures were shown. 
 39
2.3.8 Infiltration of immune cells during infection with B. pseudomallei 
 
Infiltration of immune cells was observed in the cross section slides of infected organs. 
To define the various cell-types present in the infected spleen, surface marker staining with 
specific antibodies and flow cytometry were employed. Splenocytes were isolated from low dose 
infected and control BALB/c and C57BL/6 mice. Among the cell types examined, we observed 
an obvious increase of neutrophils (which is Ly6Ghigh cells in infected organs at 48 h, in the 
spleen of BALB/c (from 4.2% to 29.5%) and C57BL/6 mice (from 2.2% to 16.7%) (Figure 8A).  
At 48 h post-infection both the Ly6Ghigh and Ly6Glow populations in the total splenocytes 
increased for both strains of mice. There was also an increase in CD11b positive cells (Figure 
8B), which could be contributed by either the neutrophils or monocytes, as the Ly6G+ cells also 
co-express CD11b marker. 
Collectively, these data indicate that there are inherently more neutrophils in the spleen of 
BALB/c mice at steady state, as well as a higher influx of neutrophils and monocytes upon 
infection.  It was likely that the high bacterial loads in the organs of BALB/c mice resulted in 
greater infiltration of innate immune cells such as neutrophils, especially between 24-48 h post-
infection.  However, the correlation of the transient IFN-γ peak with infiltration of these cells is 
less direct as inflammation and pathology in the organs get progressively worse while IFN-γ 














Figure 8  Infiltration of neutrophils and monocytes to the spleen of infected mice. BALB/c and C57BL/6 mice were infected intranasally with 
50 CFU of B. pseudomallei strain KHW, while the control mice were treated with PBS only. At 48 hr post-infection, the control and infected mice 
were sacrificed and the spleen removed, stained, washed and analysed by FACScan.  (A) Ly6G was used as a neutrophil marker in the total 
splenocytes analysis. (B) The monocytes and neutrophils were stained with anti-CD11b antibodies. 





Knowledge about the immunopathogenesis of B. pseudomallei is limited, and 
even less is known about mucosal infection. Based on the murine model of differential 
susceptibility to intravenous infection of B. pseudomallei (Leakey et al. 1998), we 
demonstrated that the relative susceptibility of BALB/c mice compared to C57BL/6 mice 
was also observed with intranasal infection. Our results showed that BALB/c mice were 
highly susceptible to intranasal infection with a LD50 of 32 CFU, whereas the LD50 of the 
relatively resistant C57BL/6 mice was 446 CFU. Based on this result, C57BL/6 mice are 
14-fold more resistant than BALB/c in the mucosal infection route with B. pseudomallei. 
The establishment of a murine model demonstrating differential susceptibility between 
two inbred mouse strains through intranasal infection enables us to examine the host 
factors that correlate with resistance in a nasal route of infection. 
One of the most obvious differences between the two strains of mice after 
infection is the bacterial loads in their organs. The bacterial burden in C57BL/6 mice was 
very low throughout the first three days postinfection in all three organs examined, and 
bacteria were not detectable by two weeks in most animals. In contrast, BALB/c mice 
showed increasing bacterial burdens in lungs and spleens. Interestingly, the bacterial load 
in livers up to 3 days postinfection was very low, indicating an efficient clearance 
mechanism at the early stage of infection. Hoppe et al. attributed the lower bacterial 
burdens in livers than in spleens during intravenous infection to the degradation of 
bacteria within phagolysosomes of hepatocytes (Hoppe et al., 1999). The low or absence 
of bacterial burden in C57BL/6 mice is likely due to the inability of bacteria to establish 
infection in these mice, which suggests the presence of effective innate mechanisms to 
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control the growth of bacteria. The presence of IFN-γ in the spleen at 24 h post-infection 
but not in the spleen of BALB/c mice might be an indication that early IFN-γ response is 
important for protection. This early IFN-γ could allow better inhibition of bacterial 
growth and thus prevent uncontrolled production of proinflammatory cytokines. The 
delay in IFN-γ production in the BALB/c mice was likely the cause of uncontrolled 
bacterial load and hyperinflammation (including hyperproduction of IFN-γ) which lead to 
acute disease. In fact, peritoneal cell cultures from C57BL/6 but not BALB/c mice were 
shown to control and eliminate bacterial growth in vitro, and the presence of both 
macrophages and lymphocytes in the peritoneal cell cultures was necessary for this to 
occur (Leakey et al. 1998; Ulett et al. 1998). Therefore, we hypothesize that the failure of 
the innate immunity to control the infection could be the underlying factor that leads to 
susceptibility to infection. The resistance in C57BL/6 mice is partly due to efficient early 
control of bacterial growth by innate immune cells such as tissue macrophages or other 
cell types present at the sites of infection.  
Proinflammatory cytokines also contribute to the early recruitment and activation 
of phagocytes capable of killing bacteria. It is well established that the C57BL/6 mice are 
prone to develop Th1 response (characterized by high IFN-γ and IL-2) that confers 
resistance to intracellular pathogens; whereas the BALB/c mice are believed to prone to 
develop Th2 response, which causes them to be more susceptible to intracellular 
pathogens. It is possible that the susceptible BALB/c mice could not mount an adequate 
inflammatory response during B. pseudomallei infection, while C57BL/6 mice being 
prone to develop Th1 response, could mount a sufficient response. However, we have 
previously reported that both strains of mice made IFN-γ, TNF-α, IL-1β, and IL-6, 
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confirming the results of Ulett et al. (2000), who had found no cytokine polarization 
(neither Th1 nor Th2 response) in the spleens and livers of C57BL/6 and BALB/c mice. 
Prominent induction of IFN-γ was observed in all three organs of BALB/c mice, and IL-6 
was observed in their spleens and lungs (Liu et al, 2002). We also found high levels of 
proinflammatory cytokines including IFN-γ, TNF-α and IL-1β both locally (in the nasal 
mucosa) and systemically (in the serum, Liu et al, 2002). Furthermore, hyperproduction 
of IFN-γ  is a transient response that is associated with higher bacterial loads, tissue 
pathology and disease progression and severity. In contrast, C57BL/6 mice responded to 
the infection with a moderate and transient induction of an inflammatory response that is 
effective in controlling the bacterial growth. Taken together, our results indicate that 
there is no lack of inflammation in BALB/c mice. In fact, both local and systemic 
hyperproduction of IFN-γ in BALB/c is not protective and may lead to septic shock (Car 
et al. 1994; Heremans et al. 1990). 
In order to study the effects of high dose challenge on the survival, pathology, and 
innate IFN-γ response in C57BL/6 mice and to examine if the production of IFN-γ is a 
result of acute infection due to high bacterial loads, comparisons were made between the 
high dose and low dose challenged mice. High dose infection of C57BL/6 mice with 
5,000 CFU of virulent B. pseudomallei caused death within 10 days mimicking the 
disease progression of BALB/c mice.  High bacterial load in the blood was observed 
starting from day 1 after infection, peaking on day 2, and the number of bacteria was 
undetectable on day 4 after infection. The hyperproduction of IFN-γ was transient and it 
is again associated with the peak in bacterial loads in the serum, lung, liver, spleen and 
brain, and with tissue pathology. Although the serum bacterial load in the high dose 
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challenged C57BL/6 mice reached a moderate amount on day 1(Figure 5A), the levels of 
IFN-γ did not increase immediately, as there was a delay in the induction of IFN-γ 
expression at both the transcriptional and translational levels. This could be an indication 
that a threshold level of bacteremia was needed for the hyperproduction of IFN-γ  to take 
place. When most of the bacteria were removed from the blood, there was a drastic drop 
in the IFN-γ  level on day 4 post infection. In addition, the removal of bacteria from the 
systemic circulation could also be an effect of organ tropism of B. pseudomallei. These 
were likely to be the contributing factors leading to the increased bacterial loads in 
various organs. The hyperproduction of IFN-γ could facilitate the recruitment of immune 
cells into the sites of infection, as shown by the increased neutrophil infiltration into the 
infected spleen. However, it remains to be determined whether the phagocytic cell 
infiltration is causing tissue damage. There could be irreversible effects due to the 
hyperproduction of IFN-γ and an overeactive inflammatory response. This may partly 
explain why despite a transient bacteremia and hyperproduction of IFN-γ in the high dose 
challenged C57BL/6 mice, there was still a progressive disease leading to death within 10 
days.  
Interestingly, the number of bacteria in the liver and brain show an upward trend 
on day 4 post-infection while the number of bacteria in the lung and spleen plateaus off 
on day 4. The recruitment of immune cells into the sites of infection could be different in 
their ability to control the bacterial growth due to the difference in cell types recruited 
and the variation in resident innate immune cells found in each of these organs.  The 
presence of bacteria in the brain suggests the ability of the virulent B. pseudomallei to 
cross the blood brain barrier (BBB), and interferes with the neurological function of the 
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host. Invasion of bacteria into the brain could be a consequence of the intranasal infection 
route which allows the bacteria to gain better access to the brain after invading through 
the nasal cavity. Several cases of neurological melioidosis had been reported in human, 
indicating that B. pseudomallei can also invade the central nervous system of human and 
lead to abscesses (Currie et al., 2000; Chadwick et al., 2002). 
The infiltration of various leukocyte populations in the spleen of low dose B. 
pseudomallei infected mice were most obvious from 48 h post-infection onward, when 
the bacterial load reached a highest point and pathology was more obvious. Infiltration of 
neutrophils and monocytes to the spleen was observed in all the infected mice, as shown 
by the increase in the percentage of Ly6G+ and CD11b+ cells in the total splenocytes.  
Greater percentage of infiltrating cells was observed in the relatively susceptible BALB/c 
mice as compared to the more resistant C57BL/6 mice due to higher bacterial loads and 
more severe inflammation. No obvious changes in other leukocyte populations were 
detected. However, Ly6G+ cells also co-express CD11b, thus further staining with 
monocytes specific antibody (such as anti-F4/80 antibody) or microscopic examination of 
the morphology of nucleus is therefore needed to distinguish the infiltration of 
neutrophils and monocytes. Micro-abscesses could be found in the infected lungs and 
spleens of BALB/c mice and high dose infected C57BL/6 mice from 48 h post-infection 
onward. Hence, the kinetics of immune cells infiltration correlates with tissue pathology, 
bacterial loads in the infected organs and hyperproduction of IFN-γ.  
          In conclusion, this study is novel and important in establishing a mucosal 
infection model of B. pseudomallei where the effect is not limited to the mucosa but also 
systemic, as seen by the spread of bacteria systemically into other organs and the 
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detection of proinflammatory cytokines such as the IFN-γ  in the blood. This could 
represent a physiologically relevant model of human infection where the route of 
infection is through inhalation, resulting in pulmonary involvement and eventually spread 
to the bloodstream, causing septicemia, if infection can not be controlled early and 
effectively at the mucosa. Early host resistance correlates with moderate inflammation, 
while hyperinflammation was observed in susceptible mice. It is very likely that there is 
an ineffective control in susceptible animal, resulting in the increase in bacterial load, 
which then triggers the hyperinflammation. Not only is the hyperinflammation occurring 
too late in the susceptible mice, it is likely to cause pathology. Thus, the hyperproduction 
of IFN-γ observed in this study was likely the effect of hyperinflammation resulting from 
inability to control bacterial growth. This resembles acute melioidosis in patients. Those 
patients with acute melioidosis exhibit hyperproduction of IFN-γ likely as a results of 
uncontrolled growth of bacteria (Lauw et al., 1999). Human beings also show differential 
susceptibility to acute melioidosis, with diabetic patients being highly susceptible to acute 
disease. Diabetes mellitus has been shown to result in impaired chemotaxis, 
phagocytosis, oxidative burst, and bactericidal activity of phagocytes (reviewed by Cheng 
et al., 2005). Besides impaired innate immune functions, diabetic individuals were shown 
to have constitutive inflammation (Pickup 2004; Wellen et al., 2005) which predisposes 
them to acute disease. Hence, the failure of innate immunity to control the infection is 
likely to be the underlying factor that leads to susceptibility. The early IFN-γ response 
(within the first 24h after infection) observed in the C57BL/6 mice could be important for 















B. pseudomallei is intrinsically resistant to multiple existing antibiotics causing 
great difficulty in the treatment of melioidosis. Despite the use of antibiotics in therapy, 
the case mortality of melioidosis could remain as high as 40 % (Angus et al., 2000), 
which mean that antibiotic treatment for the disease could not effectively reduce the high 
mortality rate. Furthermore, relapse of disease is possible even after extended period of 
antibiotics administration. In some areas where there is a lack of quick and efficient 
diagnosis, the choice of treatment might be affected and treatment delayed. This would in 
turn lead to more severe disease causing higher mortality rate. Therefore, vaccines that 
can prevent the infection are desirable to those who live in the endemic areas. In addition, 
B. pseudomallei has the potential to be used as bioterrorism agent. Hence, a melioidosis 
vaccine would benefit both military personnel and those who are at risk from biological 
attack. 
 
Previous study by Ho et al. (1997) on Burkholderia pseudomallei polysaccharide 
specific antibodies in melioidosis patients demonstrated that production of IgG1 and 
IgG2 antibodies were found by all patient groups (including those with localized 
infection and those who survived or succumbed to infection).  IgG3 response was only 
seen in survivor of septicemic infection, while IgG4 was not detectable (Ho et al. 1997). 
Another study on the humoral immune responses against culture filtrate antigen of B. 
pseudomallei in melioidosis patients revealed that IgG1 and IgG2 were the predominant 
subclasses, while only low amount of IgG3 and IgG4 were detected (Chenthamarakshan, 
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Kumutha et al. 2001). Although the precise role of each of the IgG subclasses is not fully 
understood, human IgG1, IgG2 and IgG3 are known to mediate the classical complement 
pathway. IgG1 and IgG3 are also known to bind to Fc receptor on mononuclear cells 
including macrophages and monocytes which play important roles in influencing cell-
mediated immunity (Alexander et al., 1980). Phagocytosis of the opsonized-microbes 
will be enhanced through binding to the strong affinity receptor the FcγRI (CD64) and 
C3b complement (Khalife et al., 1989). Due to their relatively weaker affinity to the 
FcγRI, IgG2 is relatively inefficient at complement activation, whereas IgG4 is unable to 
activate complement at all (Kuby, 1997). In mice, the high affinity FcγRI receptor 
preferentially binds IgG2a and IgG2b antibodies, where IgG2a has the strongest 
opsonizing activity (Abbas et al., 2000). 
 
Previous studies had demonstrated a partial protection of animal against challenge 
with B. pseudomallei using both polyclonal antiserum and monoclonal antibody raised 
against B. pseudomallei flagellin, lipopolysaccharide (LPS) and a tentanus toxin-
polysaccharide glycoconjugate in a diabetic infant rat model (Brett et al., 1994; Bryan et 
al., 1994). Besides, glycoconjugate molecules that incorporated both flagellin protein and 
polysaccharide antigens had also been synthesized and tested in the diabetic rat model 
(Brett et al., 1994). Although such strategy augmented immune responses against both 
the flagellin and polysaccharide of the vaccine conjugates, resulting in desirable 
immunoglobulin class switching and passive protection conferred by the immunoglobulin 
fraction, the efficacy of the vaccine has yet to be validated in a live bacteria challenged 
animal model. Recently, Nelson et al. (2004) reported that immunization with either LPS 
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or capsular polysaccharide of B. pseudomallei conferred partial protection to BALB/c 
mice against intraperitoneal route, but not the intranasal route of infection by virulent  B. 
pseudomallei strain (Nelson, Prior et al. 2004). Interestingly, mice vaccinated with LPS 
were found to develop predominantly IgM and IgG3 responses which conferred optimal 
protection. In contrast mice immunized with capsular polysaccharide developed a 
predominantly IgG2b response that delayed the time of death as compare to the control 
mice after infection (Nelson, Prior et al. 2004). That was the first time antigens protective 
by active immunization were identified, suggesting that polysaccharides might have the 
potential to be developed as vaccine candidates against melioidosis. In another study 
conducted by Hoppe et al. (1999) on the antibody responses in the BALB/c and C57BL/6 
intravenous infection model, IgM, IgG1, IgG2a, IgG2b and IgG3 were detected in the 
serum of the relatively resistant C57BL/6 mice while only IgM and low levels of IgG1, 
IgG2b, and IgG3 was found in the susceptible BALB/c mice on the 11th day post-
infection. In mice, immunoglobulin isotypes switching from IgM to IgG2a (Th1-like 
IgG) is promoted by IFN-γ, a Th1 cytokine, whereas IgG1 subclass (Th2-like IgG) 
switching is induced by IL-4 produced by Th2 cells (Finkelman et al., 1990). Based on 
this idea, the authors attributed the resistance of C57BL/6 mice to the higher IgG2a/IgG1 
ratio compared to BALB/c mice, indicating the protective role of Th1-type humoral 
immune response (Hoppe et al., 1999). Since then, no one has investigated the humoral 
immunity to the bacteria in animal model in greater detail, particularly during much later 
time points of infection. Our group has reported previously that low dose intranasal 
infection of C57BL/6 mice with 50 CFU of B. pseudomallei did not lead to acute disease, 
and the infected mice could survive up to three months after infection (Liu et al., 2002). 
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We also demonstrated that low dose infection could confer protection of C57BL/6 mice 
to subsequent high dose challenge and the protection correlates to both serum IgG and 
mucosal IgA responses (Liu et al., 2002). Thus, as a test of principle, it is possible to use 
a low dose infection as an immunization dose to examine whether a protective immune 
response can be elicited and whether the type of antibody response correlates to 
protection conferred upon a high dose bacteria challenge. 
 
It has been well-characterized that mucosal vaccines are very effective at eliciting 
high levels of systemic IgG as well as secretory IgA and cell-mediated responses, 
including cytotoxic T lymphocytes (CTLs) activation (Elson et al., 1994). Hence, 
intranasal immunization of pathogen-specific antigen would confer the mucosal and 
systemic protection against the infection of the pathogen of interest. In this study, the 
feasibility of intranasal immunization of recombinant flagellin (r-FliC) as potential 
vaccine candidate was investigated. The B subunit of cholera toxin (CTB) was used as 
adjuvant for delivery of flagellin to the mucosal-associated lymphoid tissue (MALT). 
Cholera toxin (CT) subunits have been shown to induce persisting IgA antibodies and 
circulating antigen-specific IgG antibodies (Sultan et al., 1998).  CTB is the non-toxin 
and relatively safer adjuvant as compared to CT and it has been extensively used as a 
mucosal adjuvant (McKenzie et al., 1984; Olive et al., 2002; Guzman, 1999). Besides 
stimulating mucosal antibody responses, it has been shown to increase uptake of antigen 
across the mucosa and promote antigen-presentation of dendritic cells, B cells and 
macrophages by indirect upregulation of co-stimulatory molecules on antigen presenting 
cells (George-Chandy et al., 2001).  
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The objective of this study is to examine whether purified recombinant flagellin 
can be used as mucosal vaccine to confer protection in susceptible BALB/c mice against 
B. pseudoamlei challenge. The antibody responses and IgG subclasses were examined to 
study the types of antibody responses induced by the flagellin immunization. The ratio of 
IgG2a to IgG1 subclass was used as an indirect indication of either Th1 or Th2 response.  
In addition, the kinetics of humoral response in the low dose-high dose intranasal 
C57BL/6 infection model was investigated. The IgG subclasses induced after low-dose 
bacteria and high-dose challenge were also examined to see if there is any correlation 
between the types of antibody responses (Th1 or Th2) with the protection against high 
does infection in C57BL/6 mice.  
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3.2 Materials and methods. 
 
3.2.1 Mice 
Female 6-8 week old C57BL/6 and BALB/c mice were purchased from the 
Laboratory Animals Center of the National University of Singapore. They were housed in 
polypropylene cages with a bedding of wood shavings and were fed on a diet of 
commercial pellets (Glenforrest Stock Feeders, Perth) and potable water ad libitum.  All 
experimental procedures on animals and infection were approved by the IACUC of NUS. 
 
3.2.2 Bacteria 
Escherichia coli (E. coli) (M15-pQE30.fliC) expressing recombinant flagellin (r-
fliC) gene of B. pseudomallei strain ATCC 23343, was obtained from Dr Chua Kim Lee. 
Virulent Burkholderia pseudomallei strain KHW used in this study is a local clinical 
isolate from a fatal case of melioidosis in Singapore. The isolate was identified as B. 
pseudomallei based on colony morphology, API20 NE tests (BioMerieux, Marcy 
I’Etoile, France), and 16S RNA sequence. All the procedures were approved by the 
Institutional Biosafety Committee (IBC) of NUS. 
 
3.2.3 Expression of Recombinant Flagellin (r-FliC) 
The full-length fliC sequence (1164bp, Gene Bank Accession Number: U82286) 
of B. pseudomallei strain ATCC23343 was cloned into pQE-30 vector (QIAGEN), which 
is based on a T5 promoter transcription-translation system. E. coli strain M15 that has 
been transformed and harboring the recombinant plasmid pQE-fliC were streaked from 
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the glycerol stock onto a freshly prepared LB agar plate supplemented with ampicillin 
(100μg/ml) and kanamycin (25 μg/ml) and cultured at 37 °C for 16 h. A single colony 
was then inoculated into 20 ml of LB medium (Appendix I) containing ampicillin (100 
μg/ml) and kanamycin (25 μg/ml) as the starter culture. The starter culture was incubated 
at 37 °C overnight with vigorous shaking at 200 rpm. On the next day, the starter culture 
was diluted 1:50 intro 1 L fresh LB containing antibiotics and cultured at 37 °C with 
continuous agitation at 200 rpm until an OD600 of 0.6-0.8 (approximately 3h). The culture 
was induced to express recombinant flagellin (r-FliC) by addition of isopropyl-β-
thiogalactopyranoside (IPTG) to a final concentration of 1mM for 3 h at 37 °C. Cells 
were then harvested by centrifugation at 4,000 RCF using the JLA 10.5 rotor at 4 at °C 
for 20 min. The cell pellet was stored at -20 °C until purification. The recombinant 
flagellin was expressed with an N-terminal 6xHistidine tag and has a molecular weight of 
40 kDa. The native flagellin of B. pseudomallei has a theoretical molecular weight of 
39.1 kDa and an apparent molecular mass of 43.4 kDa by SDS-PAGE (Brett et al., 1994). 
 
3.2.4 Purification of recombinant flagellin 
 
3.2.4.1 Preparation of cleared lysate under denaturing condition 
The bacteria pellet was allowed to thaw for 15min on ice and resuspended in 
buffer B (Appendix I). A total of ~10ml buffer is required for pellet harvested from 1 L 
culture. The suspension was then subjected to sonication for 10 min at room temperature. 
Sonication was repeated until the solution became translucent, an indication of complete 
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lysis of the bacteria. The cleared lysate was centrifuged at 10,000 RCF for 20 min at 4 °C 
using the JA 20 Rotor.  
 
3.2.4.2 Purification of protein under denaturing condition 
Ni-NTA column was washed and preincubated with buffer B (Appendix I) in the 
separation column. The supernatant of the cleared cell lysate were transferred into the 
column containing the preincubated resin. The resin was allowed to mix with the cleared 
cell lysate supernatant, and was then transferred into a 50 ml Falcon tube, placed into a 
beaker filled with ice, and put onto a shaker. The shaker was set to shake at 200 rpm in 
the cold room. After 1-2 h of incubation, the cleared lysate-resin mixture was transferred 
back into the column with the bottom cap still attached. The bottom cap was removed, 
and the flow-through collected for SDS-PAGE analysis. The column was washed 10 
times with buffer C (added with 0.5 % deoxycholate, see Appendix I). The first and last 
fractions were collected separately and the rest of the fractions were pooled into one tube 
for SDS-PAGE analysis later. The recombinant flagellin (r-FliC) protein was eluted 4 
times with 0.5 ml of buffer D (see Appendix I), followed by another 4 times with 0.5 ml 
of buffer E (see Appendix I). Fractions collected were analyzed by SDS-PAGE to check 
for purity. Monomer of the protein will be eluted by buffer D (pH 5.9), while multimers 
and aggregates will be eluted in buffer E (pH 4.5). Further washing with buffer E were 





 3.2.4.3 Analysis of purified flagellin by SDS-PAGE 
SDS-PAGE was performed according to Laemmli (1970) in a mini vertical gel 
apparatus with a 4 % stacking and 8 % or 10 % separating (w/v) acrylamide gel system 
(Appendix I). Protein samples were denatured by boiling in 1x protein loading buffer 
(Appendix I) for 3 min prior to loading onto the gel. Electrophoresis was carried out in 
SDS-PAGE electrode buffer (Appendix I) at constant voltage 80 V for about 30 min to 
allow the proteins to stack and was subsequently set at 120 V for about 1 hr. After 
electrophoresis, protein gels were removed, fixed and stained with Coomassive Blue 
R250 (Appendix I). The protein gel to be used for Western blot was not stained. 
 
3.2.4.4 Determination of protein concentration by Bradford method 
The concentrations of protein for all the fractions collected during purification 
were analyzed by Bradford Method. The 10-20 μl of samples were first mixed with 
water, and topped up to 800 μl. A series of BSA standards were also prepared (1-10 
μg/ml). Each sample was then added with 0.2 ml of Bradford Reagent, mixed by 
vortexing and allowed to stand for at least 5 min before absorbance was read at 595 nm 
with spectrophotometer. 
 
3.2.4.5 Dialysis and concentration of purified flagellin 
Fractions without visible contaminating protein were pooled and dialysed in 
dialysis bag. The protein solution were immersed in gradually reducing urea 
concentrations starting from 6 M and subsequently to 4 M, 2 M and 0 M urea solutions ( 
added with 10mM of Tris maintained at pH 8). The interval between each transfer was 2 
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h. The resulting dialysed protein was concentrated by ultrafiltration. The concentrated 
protein was subjected to filtration through filter with a 0.22 μm pore size to ensure its 
sterility. 
 
3.2.5 Immunization of mice 
Mice were divided into various groups for immunization with purified flagellin 
with or without mucosal adjuvant CTB (Sigma). PBS was used as diluent and served as 
control. After anaesthetizing with a combination of Hypnorm and midazolam, mice were 
inoculated intranasally, through one nostril with a yellow pipette tip, with the 20 or 30 μg 
of flagellin resuspended in PBS, with or without 5μg of CTB. Immunization was repeated 
at the 2nd week and the 4th week after the first immunization. 
 
3.2.6 Infection with live bacteria and protection study 
After anaesthetizing with a combination of hypnorm and midazolam, the 
immunized mice were inoculated intranasally, through one nostril with a yellow pipette 
tip with B. pseudomallei in 20 μl of PBS. Control mice were inoculated with PBS only. 
For low dose infection, 50 CFU of virulent B. pseudomallei strain KHW were used, while 
5,000 CFU of bacteria were used for high dose infection. 
 
3.2.7 Collection of serum 
To obtain the serum from the immunized animal, blood (100-150 μl) was 
collected from the lateral tail vein of mice from each group at least one week after each 
immunization or infection. Mice were anesthetized before the procedure. The blood 
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samples collected were allowed to clot at room temperature, and transferred to 4 °C to 
allow the blood clot. Sera were collected and stored at -20 °C.  
 
3.2.8 Detection of antigen specific antibodies by ELISA 
 
3.2.8.1 Flagellin Specific Antibodies 
To detect flagellin specific antibodies, 96-well plates (NUNC, Denmark) were 
coated with purified flagellin (r-FliC).  Plates were subsequently washed extensively with 
PBS-Tween and blocked with 1 % bovine serum albumin (BSA) for 2 h at 37oC.  Plates 
were washed and incubated with appropriate dilution of serum for 2 h at 37oC.  After 
further washings, goat-anti mouse total IgG, rat-anti mouse IgG1, or rat-anti mouse 
IgG2a conjugated with horse radish peroxidase (BD Pharmingen) was added at the 
appropriate dilution for 1 h at 37oC.  The plates were developed by the addition of 
tetramethylbenzidine (TMB) substrates. The reactions were stopped by addition of 2N 
H2SO4, and absorbance was measure at 450nm and 570nm with Max 190 
spectrophotometer. 
 
3.2.8.2 Burkholderia pseudomallei specific antibodies 
For detection of whole bacteria specific antibodies, similar procedures were 
followed as stated in section 3.3.10.1, except that heat-inactivated B. pseudomallei, strain 





3.2.9 Western Blot 
Flagellin (1 μg/sample) was subjected to electrophoresis on 4 % stacking-10 % 
resolving SDS-PAGE gel and electroblotted onto nitrocellulose membrane. Western blot 
hybridization was performed according to Towbin (1979), using TBST (20 mM Tris-
HCl, pH 7.5; 500 mM NaCl; 0.05 % Tween-20) containing 10 % skimmed milk as the 
blocking reagent and appropriate dilution of mouse polyclonal anti-flagellin antibodies as 
the primary antibodies. After 1 hour incubation with the primary antibodies, the 
membrane was washed three times using TBST and a 1:2000 dilution of HRP-conjugated 
goat anti-mouse IgG (Amersham Pharmacia Biotech, Buckinghamshire, England) was 
added for 1 hour. The membrane was washed again and immersed for 1 min in Enhanced 
Chemiluminescence (ECL) Western Blotting detection reagent (Amersham) for the 
detection of bound horseradish peroxidase by autoradiography. 
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3.3 Results  
3.3.1 Purification of flagellin protein (r-FliC)  
The purity of the fractions collected during the denaturing purification process 
was analyzed by SDS-PAGE. The fractions collected after addition of wash buffer C and 
elution buffer D contain other proteinaceous contaminants (Figure 9A). Fractions 
collected after addition of buffer E were much purer and relatively free of protein 
contaminants (Figure 9B). Hence, only fractions E were pooled and used for dialysis and 
subsequent experiment. Recombinant flagellin protein was subjected to dialysis to 
concentrate the protein to approximately 1mg/ml. 
 
 
Figure 9 SDS-PAGE analysis of purified flagellin protein. Lysate of M15-pQE30-r-fliC, and 
fractions collected during denaturing purification process were analysed by SDS-PAGE. The total 
amount of protein used was 4 μg for each sample. (A)Lane 1: molecular weight marker, Lane 2: 
Non-induced bacteria lysate; Lane 3: 3h IPTG-induced bacteria lysate; Lane 4: 1st wash with 
buffer C; Lane 5: Final wash with buffer C; Lane 6-10: Eluted fractions with buffer D1.  (B) Lane 
1: molecular weight marker; Lane 2-8: Eluted fractions with buffer E. 
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3.3.2 Immunization and protection study 
 
For intranasal immunization, 20 μg of r-FliC was used in the presence or absence 
of mucosal adjuvant, CTB. In the first experiment, the PBS inoculated mice died within 
11 days after infection with B. pseudomallei strain KHW. For r-FliC immunized mice, 
only 1 out of 5 mice survived beyond day 10, all mice in this group died on the 20th day 
post-infection (Figure 10A). For the CTB inoculated mice, half of the mice died by the 9th 
day, 50 % survival was observed till the 32-day post-infection. There was some delay in 
the death of mice immunized with r-FliC together with the mucosal adjuvant CTB. Only 
2 mice died between day 10 and day 12, 2 of the remaining 3 mice died on day-19 and 
day-20 and the survival rate was higher than the other three groups at any time point 
between day 7 to day 19. All CTB inoculated mice died on day 39, while the longest 
surviving mouse from the CTB+r-FliC group lasted till day 54.  
 
Since immunization with two doses of 20 μg of r-FliC did not show significant 
protection against infection with virulent B. pseudomallei, we tested the immunization 
with a higher dose of protein and with additional booster dose to see if survival would 
improve. Our results indicate the same trend, in which r-FliC added with CTB confer a 
slight delay in host death during early time point of infection (from day 4 to day 16, 
Figure 10B). In the CTB inoculated mice, 60 % died by day 7, 40 % survived till day 19. 
One mouse died on day 20 while the remaining mouse died on day 25. No protection or 
delay in host death was observed in the r-FliC immunized mice. Surprisingly, one of the 
r-FliC immunized mouse survived till 59 days post-infection.  
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In both experiments, there were mice that varied greatly in the survival duration 
from other mice within the same group. This could have been due to the use of intranasal 
route, which has the limitation of introducing inconsistent volume of antigen (and 
bacteria) into the nasal cavity of each mouse. In all experiments, most of the infected 
mice had severe weight loss due to loss of appetite, ruffled hair coat, and splenic 
abscesses at the point of death, while paralysis of hind legs, abscesses in the liver and 


























Figure 10A Survival of immunized BALB/c mice after challenge with virulent B. 
pseudomallei. Mice were divided into 4 groups, each group initially consisted of 6 mice 
(except for the r-FliC immunized group which had only 5 mice at the point of infection). 
Mice were immunized twice with PBS, CTB (5μg), purified r-FliC (20μg) or r-FliC 
(20μg) + CTB (5μg) before infection. Immunization was repeated on the 2nd week. Mice 
were infected with 50 CFU of B. pseudomallei 2-week after the second immunization and 


























Figure 10B Survival of immunized BALB/c mice after challenge with virulent B. 
pseudomallei. BALB/c mice were divided into 4 groups, 5 mice per group (except for the 
r-FliC+CTB group, which only had 4 mice left at the point of infection). Mice were 
immunized twice with PBS, CTB (5μg), purified r-FliC (30μg) or r-FliC (30μg) + CTB 
(5μg). Immunization was repeated on 2nd week and the 4th week after the 1st 
immunization. Two weeks after the third immunization, mice were challenged with 50 
CFU of B. pseudomallei and the mortality was monitored daily.  
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3.3.3 Flagellin specific antibody responses (total IgG and IgG subclasses) 
To determine whether immunization can induce a systemic antibody responses, 
the antibody titres in the sera collected after three immunizations were analysed by 
ELISA, and the isotypes of IgG subclasses were also examined. Immunization with r-
FliC induced a significantly stronger antigen specific IgG either administered 
individually or together with CTB (Figure 11A). The antibodies were mainly of the IgG1 
subclass, while only very low level of flagellin-specific IgG2a antibodies were detected.  
The ratio of IgG1/IgG2a was 4.4, 4.8 and 15.1 for CTB, r-FliC and r-FliC+CTB 
immunized mice respectively (Figure 11B). The results suggest that both CTB and FliC 
are strong Th2 inducers when used individually, and combination of the two gives rise to 















































Figure 11 Titers of flagellin specific antibodies in the serum of BALB/c mice. Mice 
were immunized with CTB, r-FliC, r-FliC+CTB, or PBS as control. Serum was collected 
after the 3rd immunization, pooled and analyzed for the total IgG (A), IgG1 and IgG2a 
subclasses (B). Each sample was tested in triplicates and error bar indicates the standard 
deviation of the assay. The ratio of IgG1/IgG2a for PBS, CTB, r-FliC, r-FliC+CTB 





3.3.4 Western blot analysis of anti-sera 
The specificity of the antibodies induced after immunization was also studied by 
western blotting. As expected, FliC immunization induced a strong antibody response 
when administered singly or together with CTB. A low level of FliC specific antibodies 
was induced in the CTB inoculated mice (at 1:100 dilution), indicating a non-specific 
induction of the humoral immune response (Figure 12). 
           1:100                                                    1:500 
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Figure 12 Western blot analysis of anti-sera specificity from r-FliC immunized mice. 
The specificity and titer of serum collected from PBS (Lane 1 and 5), CTB (Lane 2 and 
6), r-FliC+CTB (Lane 3 and 6), r-FliC (Lane 4 and 8) immunized BALB/c mice were 
tested. 1 μg of purified r-FliC were ran on the SDS-PAGE gel, blotted onto nitrocellulose 
membrane, cut into separated strips, incubated with either 1:100 (Lane 1-4) or 1:500 ( 
Lan3 5-8) dilution of the anti-sera, secondary antibody conjugated with HRP against 
mouse IgG were added, washed and signal detected by enhanced chemiluminescence.  
 
3.3.5 Specificity of antibodies against the whole bacteria  
In order to effectively control the bacterial growth during infection, the antibodies 
induced during immunization must not only be able to recognize the denatured protein, 
but also the protein present on the bacteria. Hence, we tested the specificity of the anti-
sera to the whole bacteria. Anti-sera from r-FliC immunized BALB/c recognized heat-
killed B. pseudomallei coated on the 96-well plate, while the control anti-sera showed 
low reactivity towards the bacteria (Figure 13 A). Consistent with the result obtained 
from FliC protein specific antibodies, IgG1 is the predominant IgG subclass that binds to 















































Figure 13. The antibody titers for whole bacteria. The ability of anti-sera to recognize 
whole bacteria were tested by ELISA. Heat-killed B. pseudomallei were coated onto 96-
well ELISA plate and incubated overnight to allow binding of the bacteria onto the 
ELISA plate. The plate was incubated with the diluted anti-serum from control or r-FliC 
immunized mice, the total IgG (A), IgG1 and IgG2a (B) were determined 
spectrophotometrically at 450nm, with OD570nm serving as a reference. The ratio of 







3.3.6 Low dose-high dose infection in C57BL/6 mice 
3.3.6.1  Kinetics of the antibody responses (total IgG, IgG1 and IgG2a) 
In the resistant C57BL/6 mice, a single low dose infection with B. pseudomallei could 
confer protection against a normally lethal, high dose infection (Liu et al., 2002). The low dose 
infection serves as an immunization regime to prime the immune system. In view of this, the 
kinetics of the IgG response after low dose immunization in C57BL/6 followed by a high dose 
challenge was studied, and the IgG subclasses induced was also examined to see whether they 
have any correlation to the protection against high dose challenge. The kinetics of the IgG, IgG1 
and IgG2a responses are shown in Figures 14A and 14B respectively. There was a gradual 
increase in the total bacteria specific IgG after each low dose infection. There was a 
corresponding increase in the level of specific IgG2a antibodies after every low dose infection, 
while only a low level of increment of the IgG1 subclass was observed. Therefore, it is obvious 
that low dose bacteria infection in C57BL/6 mice resulted in an induction of Th1 response as 
showed by the high IgG2a/IgG1 ratio (2.0 vs 0.7 for the control mice).  
 
Although it was found that low dose infected C57BL/6 mice can survive beyond two 
weeks or even up to 3 months after initial infection with B. pseudomallei (Liu et al., 2002). In 
present study, however, it was observed that some low dose infected and all high dose challenged 
C57BL/6 mice developed chronic infection. Eventually all infected C57BL/6 mice died of the 
disease, although the time when death occurred after the last infection varied, ranging from a few 
weeks to several months. Post-mortem examination revealed that splenomegaly and splenic 
abscesses were the most common features at the point of death. It remained to be tested whether 
reactivation of chronic infection which lead to the spread of the bacteria systemically was the 

































































Figure 14 The kinetics of the antibody responses in B. pseudomallei infected C57BL/6 mice. 
Mice were infected twice with 100 CFU of B. pseudomallei strain KHW before high dose 
challenge with 10000. Sera were collected from the tail vein one week after the each challenge. A 
1:20 dilution was made before the assay, the amount of B. pseudomallei specific antibodies 
recognizing the heat-killed bacteria coated on 96-well ELISA plates was measured 
spectrophotometrically at OD450nm, with 570nm as the reference wavelength. The total IgG 
responses are shown in Figures 6A and 6C, while the IgG1 and IgG2a responses are shown in 
Figure 6B and 6C. The results were obtained from at least 3 separate animals, and the each test 
was carried out in duplicates, with error bars indicating the standard deviation of the antibody 
titers among three different mice. The ratio of IgG2a/IgG1 for control, KHWx1, KHWx2 and 
KHW high dose infected mice was 0.74, 5.2, 2.8, and 2.7 respectively. 
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3.3.6.2 Flagellin specific antibodies (total IgG, IgG1, and IgG2a) 
To examine if flagellin is the major immunodominant antigen for the induction of 
antibody responses by whole bacteria, we determined the titer of flagellin specific 
antibodies in the serum of B. pseudomallei challenged C57BL/6 mice. A strong r-FliC 
specific antibody response was observed in C57BL/6 mice after 3 repeated infections 
with low dose of B. pseudomallei (Figure 15). However, the level of flagellin specific 
total IgG decreased after high dose infection. The level of flagellin specific IgG2a 
antibodies was higher than IgG1 antibodies, indicating a Th1 response. Besides, there 
was no difference in the FliC-specific IgG2a/IgG1 ratio after high dose challenge in 
C57BL/6 mice compared to the low dose infected group. These results suggested a 
control mechanism that was able to prevent flagellin on the intact bacteria from 
stimulating a strong Th2 response. It could also be due to the low abundance of flagellin 
present on the intact bacteria compared to high dose of purified flagellin used in the 
experiments described earlier. High dose of antigen is known to stimulate a Th2 
response, while low dose of antigen tends to activate a Th1 response (Constant et al., 
1997). Recently, the soluble flagellar protein (FliC) of Salmonella was found to stimulate 
Th2 response while FliC in its native form bound to live bacteria induced IgG2a class 


























Figure 15 The titer of flagellin specific antibodies in the low dose and high dose 
infected C57BL/6 mice. Anti-sera from the naïve, low dose or low dose followed by 
high dose B. pseudomallei infected mice were tested for the presence of r-FliC specific 
antibodies. Each sample was tested in triplicate and error bar indicate the standard 
deviation of the assay. The ratio of IgG2a/IgG1 for naïve, low dose KHW infected 
(KHWx3) and high dose KHW infected mice was 1.4, 1.3 and 1.30, respectively. 
 
3.4 Discussion 
There is currently no licensed vaccine to prevent B. pseudomallei infection. 
Vaccine development is difficult because B. pseudomallei is an facultative intracellular 
pathogen that can invade multiple cell types (Jones, Beveridge et al. 1996) and 
effectively hide from the immune system for extended periods of time. Effective 
vaccination against intracellular pathogens therefore requires the induction of a 
cytokines-mediated cellular response (Th1 type response) for clearance of the 
intracellular pool of bacteria to prevent potential reactivation of the disease. It had been 
shown that a protective host response against B. pseudomallei requires IFN-γ, TNF-α, 
and IL-12 cytokines in murine model, indicating the importance of a Th1 response 
(Santanirand, Harley et al. 1999). The relative importance of B cell versus cell-mediated 
immunity in B. pseudomallei infection has not been established. Although it was 
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demonstrated that a specific cell-mediated immune response in survivors of acute 
melioidosis suggests its importance in long-term control and prevention of relapse 
(Barnes et al., 2004; Ketheesan et al.,  2002). However, the absence of evidence to 
suggest that HIV infection is a risk factor for melioidosis in Thailand, despite its 
prevalence argues against the importance of CD4 T cells (Chierakul et al., 2004). 
Although cell-mediated immune response is likely to be indispensable against 
intracellular bacteria, antibodies that enhance bactericidal and phagocytic activities of 
innate immune cells (such as macrophages, dendritic cells and neutrophils) may have 
important roles to play during the initial clearance and control of the bacteria infection. 
Hence, a humoral response against bacterial surface antigens could conceivably help to 
prevent infection.  
In several bacterial pathogens including Samonella enterica serovar Typhimurium 
and Vibrio cholerae, virulence has been correlated with flagella and bacterial motility 
(Carsiotis et al., 1984; Gardel et al., 1996). Flagella were recently shown to be the 
virulent factor of Burkholderia pseudomallei, and it was demonstrated that polyclonal 
anti-sera raised from injection of rabbit with recombinant flagellin (r-FliC) could 
significantly reduce the motility of the bacteria (Chua et al., 2003). Our results show that, 
despite the strong humoral immune responses that were elicited upon immunization of 
BALB/c mice with recombinant flagellin protein (with or without CTB as mucosal 
adjuvant), no protection against live bacteria challenge was conferred. Besides, the strong 
IgG1 response giving rise to a high IgG1/IgG2a ratio was an indication of a strong Th2 
response. The ratio of IgG1/IgG2a was higher when CTB is administered together with 
FliC protein, indicating an enhancement of Th2 response.  Although there was some 
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delay in the host mortality at early time point post-infection, the protection conferred by 
the strong antibody responses to flagellin was minimal. Our results suggest stronger 
influences contributed by other virulence factors allow the bacteria to evade the host 
immune defense, in spite of its reduced motility. Besides, we demonstrate that 
recombinant FliC protein is a very potent immunogen even in the absence of mucosal 
adjuvant (CTB), as a strong systemic IgG was elicited. The fact that FliC immunized 
mice died at much earlier time points then mice administered with CTB alone could be 
due to hyperinflammatory responses induced by flagellin. Our result is consistent with 
the existing evidence showing that recombinant flagellin is a highly potent 
proinflammatory soluble-protein, which is able to induce a Th2 response (Cunningham et 
al., 2004).  However, we did not test whether FliC immunization (with or without CTB) 
elicit any local IgA response on the mucosal surface due to insufficient resources. This 
would be important to look at in the future as the entry of the bacteria is through the 
mucosa, and IgA would serve as a first-line of defense. A recent study has shown that 
mucosal immunization with purified flagellin from Salmonella induced systemic and 
mucosal immune responses characterized by high IgM-IgG response, as well as strong 
mucosal IgA response (detected in the feces) in a mouse model (Strindelius et al., 2004). 
Hence, it is likely that similar responses were elicited after immunization with r-FliC. 
It is known that B. pseudomallei flagellin is immunogenic in patients with 
melioidosis (Charuchaimontri et al., 1999). Therefore, a DNA vaccine was generated 
using the FliC flagellin structural gene and tested as one of the potential vaccine 
candidates (Warawa and Woods, 2002). This gene was incorporated into a suitable 
mammalian expression vector and inject intramuscularly into either Syrian golden 
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hamsters or diabetic rats. The DNA-immunization of FliC was not effective in protection 
against B. pseudomallei infection following four immunizations, although immune 
response to flagellin was found and IFN-γ was expressed in the spleen, which suggests a 
Th1 response (Warawa and Woods, 2002). However, study by Chen et al. (2005) showed 
that immunization of BALB/c mice with plasmid DNA encoding flagellin (pcDNA/fliC) 
conferred 83 % protection against live bacteria infection on day 7 (Chen et al., 2005). The 
protection correlated with induction of a stronger IgG2a over IgG1 antibody response and 
expansion of IFN-γ-secreting cells in spleen after immunization, and there was a 
significant reduction in the bacterial loads in the spleen and liver of the pcDNA/fliC 
immunizaed mice after infection compared to control mice (Chen et al., 2005). Recently, 
the same group has reported the used of CpG-modified plasmid DNA encoding flagellin 
was able to induce strong Th1-skewed flagellin specific responses and such strategry 
conferred better protection against B. pseudomallei infection (Chen et al., 2006). 
Therefore, it is obvious that flagellin can induce either Th1 or Th2 response depending on 
the immunization protocols. The variation in the results of these studies could be due to 
the differences in the choice of adjuvant and dosage of antigen used, immunization 
protocols, type of immune responses induced, infection routes, animal models and 
virulence of the infecting strains. We did not examine the cell-mediated immune 
responses such as T-cell proliferation and CTL activation due to the constraint of 
resources and facilities at the point of investigation. Future study should include 
measurement of cell-mediated immune responses after immunization. 
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In the low dose infection C57BL/6 model, we demonstrated a strong local IgA 
and systemic IgG responses after infection with low dose of bacteria (Liu et al., 2002). 
The study on the kinetics of responses after infection reveals that specific IgG as well as 
the corresponding IgG subclasses (particularly the IgG2a) increased steadily after each 
low dose infection in C57BL/6 mice. The high IgG2a/ IgG1 ratio is an indication that a 
Th1 response was induced. However, the use of anti-IgG2a for ELISA could lead to 
underestimation, as it was reported that inbred mouse strains with the Igh1-b allele 
including C57BL/6 do not have the gene for IgG2a and express the IgG2c isotype 
instead. The anti-IgG2a antibody cross-react inadequately against IgG2c in immunoblot 
and ELISA (Martin et al., 1998). Hence, anti-IgG2c should be used in future experiment. 
Nonetheless, our results show that the protection of low dose infected C57BL/6 mice 
against subsequent high dose intranasal B. pseudomallei infection could be attributed to 
the presence of Th1 type antibody response as well as cell-mediated immune responses. 
B. pseudomallei is an intracellular pathogen, therefore both the cellular arm and humoral 
arm of immune responses are needed for effective control of the bacteria in vivo. The 
presence of strong Th2 response is therefore insufficient for protection against severe 
disease. Although we did not look at the cellular immune response, many studies has 
shown that protection against B. pseudomallei infection required a functional Th1 
response in both human and animal studies (Healey et al. 2005; Govan et al. 2004; 
Barnes et al. 2004). Recently, a similar primary-boost-lethal challenge infection model 
was established by Ulett et al. (2005). This study reported that low dose immunization of 
both the BALB/c and C57BL/6 mice conferred partial protection against subsequent 
lethal challenge (10XLD50) (Ulett al, 2005). It was demonstrated that protection against 
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B. pseudomallei infection required both the functional humoral and cell-mediated 
adaptive immune responses, in a study using heat-killed bacteria pulsed dendritic cells as 
a vaccine delivery vector for BALB/c mice immunization (Healey et al., 2005). Haque et 
al. (2006) also pointed out the importance of T cells in both the innate and adaptive 
immunity against B. pseudomallei infection. However, the fact that all infected mice 
eventually died from the infection is an indication of the presence of chronic infection 
and the protection against high dose challenged conferred by low dose infection was 
mainly through preventing the development of acute disease, which causes rapid death. 
This explains why patients suffer from melioidosis require long term administration of 
antibiotics to prevent relapse.  
In conclusion, this study and the published data from other groups have proven 
the principle that flagellin is indeed one of the immunodominant antigens of B. 
pseudomallei. By using the right design, flagellin could be used as a good candidate 
antigen for vaccine development. Besides, our results, as well as those of others, suggest 
that an effective vaccine for protection against B. pseudomallei infection require 
stimulation of both the cell-mediated immunity as well as the humoral (antibody-
mediated) immunity. Hence, vaccine design should incorporate mixture of antigens with 
appropriate adjuvants that could stimulate both the strong IgG2a response and cellular 
immunity. We have chosen to examine humoral response due to the ease of manipulation. 
Future studies could entail examination of T cell response and include immunization of 
the relatively resistant C57BL/6 mice for comparison. In fact, examination of innate 
immune responses is also critical because it can affect the type of adaptive immune 
























Innate immunity is important for the initiation of antimicrobial defense 
mechanisms. Major innate immune cells such as macrophages and dendritic cells 
recognize microbial products (including exotoxins, endotoxins, and bacterial cell wall 
components) and initiate responses that ultimately mobilize nonspecific and organism-
specific acquired immunity. Cytokines are important immune mediators produced during 
the initiate phase of infection. One of their major roles is to help to regulate inflammatory 
response during both innate and adaptive immune response.   
IFN-γ  is a Th1 cytokine that plays a key role in the regulation of both innate and 
acquired antimicrobial immunity, especially during infection with intracellular bacteria. 
The expression of IFN-γ involves complex intereactions between accessory cells, such as 
macrophages and dendritic cells, and T lymphocytes and natural killer (NK) cells 
(Shtrichman and Samuel, 2001). IFN-γ enhances antimicrobial immune responses by 
stimulating macrophage functions such as phagocytosis, respiratory burst activity, antigen 
presentation, and cytokine secretion (Boehm et al., 1997). In addition, IFN-γ have been 
found to promote secretion of opsonizing IgG2a antibodies by B cells, induction of Th1 
cell differentiation, maturation of cytotoxic T cells, and activation of neutrophils (Boehm 
et al., 19997; Hasbold et al., 1999). The functional significance of IFN-γ in antimicrobial 
defense is demonstrated by the increased susceptibilities of IFN-γ-/- and IFN-γR-/- mice to 
a variety of infections, particularly to intracellular organisms such as Listeriae and 
Mycobacteria (Shtrichman and Samuel, 2001). Besides, IFN-γ also appears to be an 
important mediator in the pathogenesis of septic shock. Specifically, IFN-γ deficient mice 
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are more resistant than wild-type mice to the development of inflammatory injury 
(Nakamura et al., 2000). Furthermore, IFN-γ production is suppressed in LPS-tolerant 
mice, an effect that appears to be secondary to decreased levels of IL-12 production 
(Varma et al., 2001). The production of IFN-γ is regulated by a variety of factors, with the 
macrophage-derived cytokines IL-12, IL-15, and IL-18 being the most-characterized 
positive regulators (Salkowski et al., 2000; Wysocka et al., 2001). These cytokines act 
synergistically to induce IFN-γ production by T lymphocytes and NK cells. Induction of 
IFN-γ  expression is also mediated through the activation of the T-cell receptor (TCR) 
complex and the interaction of CD28 with B7 proteins (Wysocka et al., 2001). 
In severe melioidosis, patients exhibit elevated serum levels of proinflammatory 
cytokines such as TNF-α (Simpson et al., 2000), IFN-γ (Brown et al., 1991; Lauw et al., 
1999) and IFN-γ induced chemokines IP-10 and MIG (Lauw et al., 2000).   Murine 
models of acute melioidosis mimic human pathology.  mRNA for proinflammatory 
cytokines such as TNF-α, IFN-γ and IL-6 were detected earlier and in more abundance in 
the organs of BALB/c mice with acute disease than the more resistant C57BL/6 mice 
when they were infected intravenously (Ulett et al., 2000). In our intranasal infection 
model BALB/c mice were susceptible while C57BL/6 mice were relatively more resistant 
to disease.  A transient hyperproduction of IFN-γ both locally and systemically was 
observed in the susceptible BALB/c mice, which exhibit acute disease followed by death 
within two weeks after infection (Liu et al., 2002). The transient hyperproduction of IFN-
γ is correlated with high bacterial loads, infiltration of leukocytes, and severity of disease. 
In another study, administering CpG DNA prior to bacterial challenge could attenuate 
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hyperproduction of IFN-γ in serum of BALB/c mice while lowering the bacterial load in 
the blood at the same time (Wongratanacheewin et al., 2004).  So although IFN-γ was 
shown to be critical in host survival in the first 24 h after infection as neutralizing 
antibodies against IFN-γ lowered the LD50 by approximately 100, 000 fold (Santanirand 
et al., 1999), hyperproduction could contribute to immune pathology and severe disease.   
The objective of this study is to compare the innate IFN-γ response to B. pseudomallei 
between C57BL/6 and BALB/c mice, and characterize the hyperproduction of IFN-γ in 
BALB/c through the in vitro stimulation of naïve splenocytes with heat-killed or live 
bacteria. It would be interesting to see if the live and dead bacteria show any differential 
cytokine responses in BALB/c and C57BL/6 splenocytes cultured in vitro. Heat-killed 
bacterial stimulation was included as it can serve as additional control. Unlike the live 
bacteria infection which can kill the infected splenocytes, heat-killed bacteria do not have 
direct effect on the viability on splenocytes. In addition, if both the heat-killed and live 
bacteria stimulate similar response in the splenocytes, it would be easier to used heat-
killed B. pseudomallei stimulation as an alternative to live bacteria infection for the 
identification cell types producing IFN-γ. Through various comparisons between BALB/c 
and C57BL/6 splenocytes we hope to identify factors which could contribute to the 




4.2 MATERIALS AND METHODS 
4.2.1 Mice.  
Female 6- to 10-week-old C57BL/6 and BALB/c mice were purchased from the 
Laboratory Animals Center of the National University of Singapore. C3H/HeJ mice were 
purchased from mouse facility of National University Medical Institutes (NUMI). They 
were housed in polypropylene cages with a bedding of wood shavings and were fed on a 
diet of commercial pellets and potable water ad libitum. Nude mice were the gift of Dr 
Theresa Tan from Department of Biochemistry, mice were bought from The Jackson 
Laboratory, Australia. All animal procedures are approved by the IACUC of NUS.  
4.2.2 Bacteria 
Virulent Burkholderia pseudomallei strain KHW used in this study is a local 
clinical isolate from a fatal case of melioidosis in Singapore. The isolate was identified as 
B. pseudomallei based on colonial morphology, API20 NE tests (BioMerieux, Marcy 
I’Etoile, France), and 16S RNA sequence. All the procedure approved by the Institutional 
Biosafety Committee of NUS.  
4.2.3 Infection with B. pseudomallei.  
Bacteria were cultured on Trypticase soy agar (TSA) (Difco Laboratories, Detroit, MI) 
for 24 h at 37 °C. Colonies were cultured overnight in LB medium, and a 1:20 dilution 
prepared and cultured for another 4 h. Bacterial number was estimated 
spectrophotometrically (1 OD600= 2×106 CFU/μl). Heat-killed or heat-inactivated bacteria 
were prepared by treatment of overnight bacterial culture at 80°C for 1 h. Dead bacteria 
were centrifuged at 10,000 g, washed twice with sterile PBS and stored at -20°C.  
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4.2.4 Preparation and stimulation of splenocytes in vitro.   
Naïve mice were killed by cervical dislocation. Spleens were removed aseptically 
and single cell suspensions prepared by passing through sterile mesh and erythrocytes 
were lysed. Cells were placed in antibiotic-free complete antibiotic-free RPMI 1640 
medium (Sigma, St. Louis, MO) supplemented with 10% Fetal Bovine Serum (FBS) 
(Hyclone Laboratories, Logan, UT), 200 mM L-glutamine, 100 units/ml penicillin and 
100 µg/ml streptomycin at a concentration of 2×106 cells in 0.5 ml of medium.  Cells 
were stimulated with heat-killed B. pseudomallei at a ratio of bacteria to cell of 5:1 or 
infected with live B. pseudomallei at a multiplicity of infection (MOI) of 5:1. Treatment 
of cells with phorbol myristate acetate (PMA) (50 ng/ml) and ionomycin (1 μg/ml) 
served as positive control. For treatments involve polymyxin B (PMB) (Sigma), 20μg/ml 
of final concentration were used. The following antibodies were used for neutralization 
studies: anti-IL-12 (polyclonal goat IgG, R&D Systems, Minneapolis, MN), goat IgG 
isotype control, anti-IL-18 (clone 93-10C, MBL, Nagoya, Japan), anti-IL-10 (clone JES5-
2A5, Biolegend, San Diego, CA), and rat IgG1 isotype control (R&D Systems). At 90 
minutes after inoculation of bacteria, 250 μg/ml of kanamycin was added into each well 
to inhibit the growth of the extracellular bacteria. Supernatants were harvested at the 
indicated time points after treatment and stored at -20°C.  
4.2.5 Cell viability determination.  
Viability of splenocytes was determined by the XTT assay kit (Roche 
Diagnostics, Mannheim, Germany) according to manufacturer’s instructions.  Briefly, 
2×106 splenocytes were cultured in 96-well plate at a final volume of 100 μl antibiotic-
free culture medium.  Infection was performed as described above.  Ninety minutes after 
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inoculation of bacteria, 250 μg/ml of kanamycin was added into each well to kill 
extracellular bacteria.  XTT labeling mixture was prepared by adding electron coupling 
reagent with XTT labeling reagent. 50 μl of labeling reagent were added into each well 
containing the splenocytes at 4 h before the measurements were recorded. The 
absorbance of the samples was measured spectrophotometrically using a microplate 
reader at a wavelength of 490 nm. 
4.2.6 Bacterial load determination.   
To estimate the total bacterial count in the infected cells cultured in vitro, 2 
million splenocytes were seeded in 1 ml of antibiotic-free medium and the cells were 
lysed with 1% Triton-X100 at 2 h or 4 h post-infection. To determine the intracellular 
bacterial load, cells were infected for 2 h before kanamycin (250μg/ml) was added. Cells 
were then harvested and lysed with 0.1% Triton-X100 2 h later. Five minutes after 
addition of lysis buffer, serial dilutions were made from the resulting suspensions and 
plated onto selective agar plates to obtain the bacterial counts. 
4.2.7 Magnetic cell separation for cell-type purification.   
Single cell suspensions from spleens of mice were washed with MACS buffer 
(PBS supplemented with 2 mM EDTA and 1% FBS) and CD4, CD8, NK cells were 
separated from the total splenocytes using anti-CD4 (Clone L3T4), anti-CD8a (Clone Ly-
2), and anti-NK (Clone DX5) microbeads respectively; while the Gr-1+ cells were stained 
with anti-Gr-1 antibodies (RB6-8C5, Biolegend) followed by incubation with streptavidin 
microbeads (all microbeads used in cell separation were obtained from Miltenyi Biotec, 
Bergisch Gladbach, Germany). Neutrophils in the total splenocytes were stained with Ly-
6G-PE followed by anti-PE microbeads before passing through the magnetic columns. 
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All separation procedures were performed according to the manufacturer’s guidelines. 
Briefly, antibody-conjugated microbeads were first added into the cells at 10 μl per 
million cells and incubated for 30 min at 4°C, the positive cells were then depleted using 
MS column or LD column (Miltenyi Biotec). Cells were washed and resuspended in 
antibiotic-free medium for further stimulation and other assays. The viability of cells 
were assessed by trypan-blue staining, and the purity of isolated cells were subjected to 
flow cytometric analysis described in section 4.2.9.  
4.2.8 Cytokine determination by ELISA.   
Supernatants were harvested at the indicated time points after treatment and 
stored at -20°C for ELISA. Mouse IFN-γ, IL-12, IL-10, TNF-α, and human IFN-γ ELISA 
assay kits were purchased from Bender MedSystem (Vienna, Austria), IL-1β and IL-18 
ELISA kits from BD Biosciences, whereas IL-6 ELISA kit was purchased from 
Biolegend. All ELISAs were performed according to manufacturer’s instructions. Cell 
culture supernatants were diluted 2 fold and assayed in duplicates. The detection limit for 
these assays were 15.6 pg/ml for IFN-γ, TNF-α, IL-6 and IL-1β, 31.2 pg/ml for IL-12 
and IL-18, 39.0 pg/ml for IL-10, and 1.5 pg/ml for human IFN-γ.  
4.2.9 Flow cytometric analysis.  
Antibodies used for cell surface marker staining were purchased from BD 
Pharmingen (San Diego, CA) unless otherwise stated: anti-CD8-PE (53-6.7, rat IgG2a), 
anti-CD4-biotin (GK1.5, rat IgG2b), anti-CD8-biotin (53-6.7, rat IgG2a) , anti-CD3-
FITC (145-2C11, Hamster IgG1) anti-Ly-6G-PE (1A8, rat IgG2a), anti-Gr-1-PerCP-
Cy5.5 (RB6-8C5, rat IgG2b), anti-pan NK-FITC (DX5, rat IgM, Biolegend), anti-TCR-
beta-biotin (hamster IgG2) . Splenocytes were adjusted to 1x106 cells and stained with 
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cell surface specific antibodies or isotype control antibodies for 30 min on ice. If the 
biotin conjugated antibodies were used, staining with SAV-PE/SAV-FITC or secondary 
antibody was performed for 15 min at 4°C. After washing, the cells were analyzed by 
FACScan (Becton Dickinson, San Jose, CA) flow cytometer.   
 
4.2.10 Intracellular cytokine staining 
Splenocytes culture stimulated with B. pseudomallei established as described 
above. Cytokine secretion was blocked by brefeldin A for 4 hr at a final concentration of 
10 μg/ml. Spleen cells were washed once with 1% FBS-PBS adjusted to 1x106 cells/tube 
and stained for cell surface markers as described above. Isotype-matched control Abs was 
included in each analysis. Cells were then fixed with 2% formaldehyde, washed and the 
permeabilized with 0.1% saponin-1% FBS-PBS buffer for 20 min. After 
permeabilization, cells were stained with FITC-conjugated anti-IFN-γ (XMG1.2, rat IgG1; 
Pharmingen) or isotype control antibody. The cells were washed twice with 
permeabilization buffer and analyzed on flow cytometer using CellQuest computer 
software (BD Biosciences). Data were analyzed by the WinMDI 2.8 software. 
4.2.11 Cytokine capturing assay for IFN-γ 
Secretion of IFN-γ was analysed with an IFN-γ secretion assay kit (Miltenyi 
Biotec) according to the manufacturer’s instructions. Briefly, infected splenocytes were 
cultured for 16 h at 37°C, 5 % CO2 in medium. At the conclusion of the assay, cells were 
incubated with optimal concentration of antibodies for surface marker staining together 
with PE-conjugated anti-IFN-γ (Miltenyi Biotec) for 30 min at 4°C. Cells were than 
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washed and analyzed by flow cytometry. Controls included isotype-matched control 
antibodies conjugated to identical fluorochromes. 
4.2.12 Isolation of human neutrophils from peripheral blood.   
Human neutrophils were isolated from healthy adult blood donors (National 
University Hospital Blood Donation Centre). Briefly the buffy coats were diluted 2-fold 
in PBS and centrifuged through a Ficoll-Paque Plus (Amersham Pharmacia Biotech, 
Uppsala, Sweden) gradient to separate the erythrocytes/neutrophils from peripheral blood 
mononuclear cells (PMBC). The plasma, PBMC, and the Ficoll layers were removed by 
Pasteur pipette, and the erythrocytes/PMNC pellets were transferred into new tubes. 
Erythrocytes were lysed by osmotic shock using 0.2 % NaCl solution and an equal 
volume of 1.6 % NaCl were then added to reconstitute to a balance salt solution 
containing 0.9 % NaCl.  To remove minute contaminating lymphocytes, monocytes and 
NK cells, neutrophils were purified by positive selection with anti-CD15 microbeads 
(Miltenyi Biotec) according to manufacturer’s instructions. Crude PMNC and CD15 
positively selected cells were seeded at 2×106 cells per well in 0.5 ml of medium and 
stimulated with live or heat-killed  B. pseudomallei in the presence or absence of human 
IL-12, IL-18 or both. Untreated cells or uninfected cells treated with cytokines serve as 
controls. Supernatants were harvested at 24 h for ELISA. 
 
4.2.13 Statistical analyses.   
Statistical significance was determined by Student’s t-test. A p value of <0.05 is 
regarded as statistically significant. 
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4.3 Results 
4.3.1 IFN-γ response in the splenocytes stimulated with B. pseudomallei in vitro 
It had been previously reported that splenocytes from naïve animals could 
produce IFN-γ in response to gamma irradiated B. pseudomallei (Lertmemongkokchai et 
al., 2001).  In order to further characterize the IFN-γ response to B. pseudomallei, we 
determined if naïve splenocytes from BALB/c and C57BL/6 these mice could produce 
IFN-γ when infected with bacteria in vitro.   Under optimal bacteria to cell ratio and 
stimulating conditions, we found that naïve splenocytes produced high amounts of IFN-γ 
with heat-killed bacteria and with live B. pseudomallei, detectable at 24 h (Figure 16).   
Although there was obvious variation of IFN-γ response from mouse to mouse, naïve 
BALB/c splenocytes consistently produced more IFN-γ in response to live B. 
pseudomallei compared to those from C57BL/6 mice whereas naïve C57BL/6 
splenocytes produced significantly higher IFN-γ than BALB/c splenocytes when treated 
with heat-killed bacteria.  Thus, the pattern of IFN-γ production to live bacteria mimics 
the infection in vivo.  Despite the differences in the response to heat-killed and live B. 
pseudomallei strain KHW, there was no difference in the level of IFN-γ upon stimulation 
with PMA and ionomycin, which was used as positive control. Hence, it is feasible to use 
this in vitro infection model to further characterize the IFN-γ response and to identify 
factors contributing to the hyperproduction of IFN-γ in the susceptible BALB/c mice 
















































Figure 16 IFN-γ response in the splenocytes of BALB/c and C57BL/6 mice stimulated with 
B. pseudomallei in vitro. Naïve splenocytes were stimulated with heat-killed virulent B. 
pseudomallei strain KHW (HK-KHW) or live bacteria (KHW).  The ratio for HK-KHW to cells 
was 5:1, whereas the MOI with live bacteria was 5:1. Supernatants were harvested at 24 h for 
determination of IFN-γ by ELISA. Two separate experiments were shown (A and B). Error bars 
refer to the means + SD of 3 mice per group. Asterisks * represent statistical significance 
(p<0.05) as determined by the Student t-test.      
                                                                                                                                                                        
 
4.3.2 Bacterial loads of the infected spleenocytes 
 
Since the higher IFN-γ production in naïve BALB/c splenocytes upon live 
bacterial infection in vitro could not have resulted from increased infiltration of cell-types 
from elsewhere, we tested the possibility that naïve BALB/c splenocytes produce more 
IFN-γ in response to live bacteria due to a poorer ability to control of intracellular 
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bacterial replication, leading to a higher bacterial load. We found that there was no 
significant difference in the total bacterial counts between the BALB/c and C57BL/6 
splenocytes. Although the total bacterial count for infected BALB/c splenocytes was 
higher than the infected C57BL/6 splenocytes at 2 h after in vitro infection, the difference 
was not statistically significant (p=0.13). Similarly, there was no difference in the total 
bacterial count at 4 h (p=0.15) (Figure 17). In three separate experiments, the intracellular 
bacterial loads were higher in BALB/c than C57BL/6 splenocytes at 4 h after infection 
(Figure 18), although the difference did not reach statistical significance in one out of the 
three experiments.  Intracellular bacterial loads at later time-points were inconsistent and 
unreliable probably due to increasing cell death. Therefore, it is possible that the 
increased IFN-γ production in infected BALB/c splenocytes was contributed by the 
















Figure 17 The total bacterial loads in the infected splenocytes. The total bacterial loads of the 
infected BALB/c and C57BL/6 splenocytes were determined at 2 and 4 hours after in vitro 
infection with B. pseudomallei.  Error bars refer to the means + SD of three mice per group.  


















Figure 18 The intracellular bacterial loads of infected splenocytes. The intracellular bacterial 
loads of infected splenocytes were determined at 4 hours after in vitro infection with B. 
pseudomallei.  Error bars refer to the means + SD of three mice per group.  Asterisks * represent 
statistical significance (p<0.05) as determined by the Student t-test.                                                                            
 
4.3.3 Cell viability of infected splenocytes from BALB/c and C57BL/6 mice 
Besides examining the bacterial loads, cell viability at various time points after 
infection was also determined to confirm that the differential IFN-γ response was not 
contributed by difference in cell viability after infection.  To optimize the cell number 
used for viability test, three different amounts of splenocytes were used to check for the 
viability first 6 hours after infection by XTT assay (Figure 19A). Two million cells were 
used for subsequent experiments. The results show that viability was not affected in 
infected cells at 5 and 10 h post infection, but there was a > 50 % reduction at 24 h post-
infection compared to the uninfected control splenocytes (Figure 19B). However, there 
was no difference in the percentages of cell viability between the infected BALB/c and 




























































Figure 19 Cell viability of infected splenocytes from BALB/c and C57BL/6 mice. 
Optimization of the cells number was carried out using three different amounts of splenocytes 
(A). Splenocytes were infected with B. pseudomallei and the cell viability was measured by XTT 
assay. Cell viability of B. pseudomallei infected splenocytes was also examined at 5 h, 10 h and 





4.3.4 Cytokine profiles in BALB/c and C57BL/6 mice after treatment with B. 
pseudomallei  
B. pseudomallei has been demonstrated to induce non-polarized Th1 or Th2 
cytokines response in vivo (Ulett et al., 2000; Liu et al., 2002). Since naïve BALB/c 
splenocytes showed a higher IFN-γ response compared to naïve C57BL/6 splenocytes 
when infected in vitro with B. pseudomallei, we determine if there are similar differences 
in other proinflammatory cytokines including TNF-α, IL-1β, IL-6, IL-12, IL-18 and the 
anti-inflammatory cytokine IL-10. Our results show that B. pseudomallei induced 
significantly higher concentrations of proinflammatory cytokines including TNF-α 
(Figure 21A), IL-1β (Figure 20B) and IL-6 (Figure 20C) at 24 h in B. pseudomallei 
infected naive BALB/c than C57BL/6 splenocytes.  However, there was no difference in 
the IL-12 levels of infected splenocytes from both strains of mice (Fig. 20D).  Although 
there was no increase in the level of IL-18 as there was a constitutive high background, 
BALB/c splenocytes still had more IL-18 than C57BL/6 (Figure 20E).  The anti-
inflammatory cytokine IL-10 was detected after infection of splenocytes from both 
strains of mice, with BALB/c producing a significantly higher amount of IL-10 as 
compared to C57BL/6, although dead bacteria did not induce much IL-10 from both 
(Figure 21F).  In response to heat-killed bacteria, BALB/c splenocytes produced more IL-
1β, TNF-α and IL-6, but significantly less IL-12 when compared to C57BL/6 
splenocytes.   Thus, it appears that the higher IFN-γ response seen in C57BL/6 to heat-
killed bacteria correlated with higher IL-12 levels, whereas higher IFN-γ response in the 
BALB/c splenocytes after infection could be due to higher basal level of IL-18, because 









































































































































Figure 20 Cytokine responses of splenocytes from BALB/c and C57BL/6 after infection with 
B. pseudomallei infection. Splenocytes were infected with live B. pseudomallei strain KHW at 
MOI of 5:1. Supernatants were harvested at 24 h post-infection for ELISA for (A) TNF-α, (B) 
IL-1β, (C) IL-6, (D) IL-12, (E) IL-18 and (F) IL-10. Asterisks * represent statistical significance 
(p <0.05) as determined by the Student t-test. 
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4.3.5 The effects of IL-12, IL-18 and IL-10 neutralizing antibodies on IFN-γ 
response 
The synergistic requirement of IL-12 and IL-18 for induction of IFN-γ is well-
established (Okamura et al., 1998). To confirm the role of IL-12 and IL-18 in B. 
pseudomallei induced IFN-γ response, neutralizing antibodies against IL-12 and IL-18 
were used to study their effects on IFN-γ production.  Addition of 1 μg/ml of neutralizing 
IL-12 antibodies could completely abrogate the production of IFN-γ by splenocytes to 
live bacteria (Figur 22A).  Similarly, neutralizing IL-18 antibodies partially lowered the 
amount of IFN-γ.  The isotype control antibodies had no effect on IFN-γ response.  
Furthermore, the dependence on IL-12 and IL-18 in the IFN-γ response was specific for 
bacterial stimulation, and not for PMA and ionomycin (Figure 21A).  As splenocytes 
from both mouse strains make IL-10, which can be antagonistic to IFN-γ, we used 
neutralizing anti-IL-10 antibodies to deplete IL-10. Neutralizing anti-IL-10 increased the 
production of IFN-γ to more than 1.5 folds to that of the control (Figure 21B). Similar 
results were observed when these neutralizing antibodies were used for infected C57BL/6 




























































































































Figure 21 The effects of cytokine neutralizing antibodies on IFN-γ response to B. 
pseudomallei.  Splenocytes were harvested from BALB/c and C57BL/6 mice and 
preincubated with anti-IL-12, anti-IL-18 or their respective isotype control antibodies 
(A), in a separate experiment anti-IL-10 was included in the assay (B) only the results for 
BALB/c splenocytes were shown here. The cells were subjected to infection with live B. 
pseudomallei strain KHW at MOI of 5:1. Supernatants were harvested at 24 h for 
determination by ELISA.  The experiment was repeated at least 3 times, representative 
data were shown. 
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4.3.6 Cell types produce IFN-γ in response to bacteria in BALB/c and C57BL/6 mice 
 
4.3.6.1 Intracellular cytokine staining  
Intracellular cytokine staining was performed on splenocytes stimulated with 
heat-killed bacteria to identify the cells types involve in production of IFN-γ response. T 
cells and Gr-1high cells were found to be the major cells type contributing to the IFN-γ 
production at 16 hour after treatment (Figure 22). However, this method did not measure 
the secreted cytokine and could be detecting preformed cytokine.  It was reported that Gr-
1high (Ly6G+) cells contains preformed IFN-γ (Kirby et al., 2002). This may explain why 
the Gr-1high cells were positively stained. Therefore, we subsequently used IFN-γ capture 
assay for a more precise identification of cell types involved.  
 
4.3.6.2 Cytokine capturing assay 
Cytokine capturing assay allows identification of specific cell type secreting the 
cytokine of interest and it does not detect cells with intracellular store of preformed 
cytokines. To determine if the cell types producing IFN-γ vary between BALB/c and 
C57BL/6 splenocytes, we measured IFN-γ production by the IFN-γ capturing assay using 
live bacteria as stimuli. In agreement with what others had found (Haque et al., 2006), 
our results show that T and NK cells were the major cells making IFN-γ (Figure 23).  The 





Figure 22 Intracellular IFN-γ staining. Splenocytes from BALB/c and C57BL/6 mice 
were isolated, 2 million cells were cultured and stimulated with heat-killed bacteria. 
Three hours before harvesting the cells for staining, BFA was added to stop the cytokine 
secretion. Cells were harvested at 16 h, stained for cell surface markers, fixed and 
permeabilized, stained with IFN-γ specific antibody conjugated with FITC, washed and 
analyzed by flow cytometry. The experiement was repeated twice with similar results, 




Figure 23 IFN-γ capturing assay. Naïve BALB/c and C57BL/6 splenocytes were 
stained with various fluorochrome-conjugated antibodies and analyzed by flow 
cytometry.  Quadrant statistics were determined based on staining with appropriate 
isotype control antibodies.  The experiment was repeated more than 3 times each with 
different animals with similar results. 
 
 
4.3.6.3 Effect of cell depletion on the production of IFN-γ 
 
To further confirm the result found in the IFN-γ capturing assay. Various cell 
types were depleted from the bulk splenocytes to examine the effect of the depletion on 
IFN-γ response to B. pseudomallei.  Only data for BALB/c mice are shown as results 
from both mouse strains are similar (Figure 24A).  Percentage of depletion for Gr-1high, 
CD4+, CD8+, DX5+, and Ly-6G was at least > 85 % as determined by flow cytometry 
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(Table 2).   However, depletion of Gr-1high cells, which also depleted a significant 
proportion of Gr-1intermediate cells as well, reduced IFN-γ production drastically both at 12 
h (data not shown) and 24 h after stimulation (Figure 24A).  NK cells and CD4 T cells 
also contributed significantly to IFN-γ production, as depletion of each of them caused 
significant reduction in the IFN-γ levels.  As Gr-1high cells were generally associated with 
granulocytes such as neutrophils, although other cell types also expressed Gr-1 with 
varying intensity, we depleted the cultures with Ly-6G antibodies to specifically deplete 
the neutrophils. Depletion with Ly-6G does not have much effect on IFN-γ production 
(Figure 24B).  All these depletions had no effect on IFN-γ  production in response to 
PMA and ionomycin, demonstrating that the depletion procedures did not incapacitate the 
cells.  Given that IL-12 is essential for the induction of IFN-γ, the reduction of IFN-γ 
could be due to a depletion of IL-12 producing populations.  In order to exclude the 
possibility, we found that depletion of various cell types did not significantly abolish the 
IL-12 in the supernatant in response to stimulations with heat-killed and live bacteria 
(Figure 25).   Although depletion of CD8 T cells did not reduce IFN-γ production, we can 
not exclude the role of CD8 T cells in contributing to IFN-γ response to B. pseudomallei, 
as they were shown by the IFN-γ capture assay and others (Lertmemongkolchai et al., 
2001; Haque et al., 2006) to produce IFN-γ.  It is possible that its removal from the bulk 
population also relieved a suppressive effect on the other cells making IFN-γ.  The other 
explanation is they contribute only little in terms of quantity to the total amount so when 




Table 2 Flow cytometric analysis of various BALB/c splenocytes populations before 
and after depletion 
 
 
 Percentage Before Depletion Percentage After Depletion % of Depletion 
Gr-1 5.1%(Gr-1high) 0.5% (Gr-1high) >90% (Gr-1high) 
CD4 24% 2.0% >91%  
CD8 16.5 3.7% >80%  
DX5 9.7% 2.6% >90%  
















































Figure 24 IFN-γ responses after depletion of CD4+, CD8+, DX5+, Gr-1+ or Ly-6G+ 
cells. IFN-γ responses after depletion of CD4+, CD8+, DX5+, Gr-1+ (A), and Ly-6G cells 
(B) were studied. Splenocytes from naïve BALB/c mice were subjected to depletion by 
MACS and treated with heat-killed or live B. pseudomallei strain KHW. PMA and 
ionomycin stimulation served as positive controls, and the untreated total splenocytes 
served as negative controls. Supernatants were harvested at 24 h for determination by 

























Figure 25 IL-12 responses after depletion of CD4+, CD8+, DX5+ or Gr-1+ cells. 
Splenocytes from naïve BALB/c mice were subjected to depletion by MACS and treated 
with heat-killed or live B. pseudomallei strain KHW. PMA and ionomycin stimulation 
served as controls, and the untreated total splenocytes served as negative controls. 
Supernatants were harvested at 24 h for determination by ELISA. Representative results 
were shown.  
 
 
4.3.7 Gr-1 expressing populations in BALB/c and C57BL/6 splenocytes 
 
Since Gr-1intermediate cells contribute to the IFN-γ response, we next determine the 
identity of the Gr-1intermediate cells in BALB/c and C57BL/6 splenocytes.  BALB/c 
splenocytes generally contained more Gr-1+ cells as well as NK cells compared to 
C57BL/6 splenocytes (Figure 26).  Besides macrophages and dendritic cells, which 
express Gr-1intermediate (Lagasse et al., 1996; Nakano et al., 2001), we found that a higher 
proportion of BALB/c CD8 T cells (about 50 %) and NK cells (about 30 %) co-expressed 
Gr-1intermediate compared to those from C57BL/6.  Hardly any CD4 T cells from C57BL/6 






Figure 26 Gr-1 expressing populations in BALB/c and C57BL/6 splenocytes. Naïve 
BALB/c and C57BL/6 splenocytes were stained with various fluorochrome-conjugated 
antibodies and analyzed by flow cytometry.  Quadrant statistics were determined based 
on staining with appropriate isotype control antibodies.  The experiment was repeated 
more than 3 times each with different animals to yield similar results. 
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4.3.8 Role of T cells in IFN-γ response 
 
 The role of T cells in IFN-γ response was studied by examining the response in 
nude mice, which do not have functional T lympochytes. The splenocytes from nude 
mice were found to produce high levels of IFN-γ to both the heat-killed and live bacteria, 
indicating redundancy of T cells in the IFN-γ  response (Figure 27). Higher level of IL-12 
was observed in cells treated with heat-killed B. pseudomallei, while only a low level of 





































Figure 27 IFN-γ and IL-12 reponse in splenocytes of Nude mice. Splenocytes from Nude mice 
were stimulated with heat-killed or live virulent B. pseudomallei strain KHW. PMA and 
ionomycin stimulation served as positive controls, and the untreated total splenocytes served as 
negative controls.  Cell culture supernatants were harvested at 24 h for ELISA. Error bars refer to 
the means + SD of 3 mice per group. 
 106
4.3.9 Role of LPS in IFN-γ response to B. pseudomallei  
4.3.9.1 The effect of polymyxin B treatment on IFN-γ response to B. pseudomallei 
To examine whether LPS from B. pseudomallei  plays any role in the 
induction of IFN-γ , polymyxin B was used to block the action of B.p-LPS. The 
results show that polymyxin B abolished IFN-γ response of splenocytes from both 
BALB/c and C57BL/6 mice to heat-killed bacteria but did not affect the response to 







































Figure 28 Effect of polymyxin B on IFN-γ response to B. pseudomllei. Splenocytes 
from BALB/c and C57BL/6 mice were stimulated with heat-killed (HK) or live 
virulent B. pseudomallei strain KHW in the presence or absence of 20μg/ml of 
polymyxin B (PMB). Cell culture supernatants were harvested at 24 h for ELISA. 
Error bars refer to the means + SD of 3 mice per group. Asterisks * represent 
statistical significance between BALB/c and C57BL/6, whereas ** represent 
significant difference between PMB treated and untreated samples (p<0.05) as 
determined by the Student t-test.      
 
4.3.9.2 TLR-4 signaling pathway is required for IFN-γ response to heat-killed 
bacteria but dispensable for the IFN-γ response to live bacteria 
To further characterize the role of LPS, and to examine the role of Toll-like 
Receptor-4 (TLR-4) signaling in the IFN-γ response to B. pseudomallei, splenocytes 
from C3H/HeJ mice which harbors the TLR-4 mutation were used for stimulation. 
Splenocytes from C3H/HeJ mice produced very little IFN-γ in response to heat-killed 
B. pseudomallei treatment, but showed a normal IFN-γ response normally to live 
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bacteria treatment (Figure 29A). Treatment with polymyxin B failed to alter the 
response to both heat-killed and live bacteria.  Despite the presence of high level of 
IL-12 in the culture supernatant, heat-killed bacteria failed to induce production of 

































































































Figure 29 IFN-γ and IL-12 response of splenocytes of C3H/HeJ mice to B. 
pseudomallei and LPS. Splenocytes from C3H/HeJ mice were stimulated with LPS, 
heat-killed or live virulent B. pseudomallei strain KHW in the presence or absence of 
20 μg/ml of polymyxin B (PMB). PMA and ionomycin stimulation served as positive 
controls, and the untreated total splenocytes served as negative controls. Cell culture 
supernatants were harvested at 24 h for IFN-γ (A) and IL-12 (B) ELISAs. Error bars 





4.3.10 IFN-γ response in neutrophils 
 
 
There had been increasing reports of neutrophils producing IFN-γ upon 
various stimulations (Ellis et al., 2002; Kirby 2002; Venuprasad et al.,  2002), 
Yeaman et al., 1998). We found that the positively selected Ly-6G+ cells, representing 
the neutrophils, were only able to make very low amounts of IFN-γ in the presence of 
IL-12 and bacteria, which would explain why their depletion did not make much 
difference to the total IFN-γ produced.  We next isolated human neutrophils from 
peripheral blood to test if they could make IFN-γ as suggested by other studies.  We 
found that neutrophil preparations varied in their ability to make IFN-γ depending on 
the presence of contaminating cell-types such as T lymphocytes.  When neutrophil 
preparations were subjected to an additional round of positive selection with CD15 
beads, giving rise to a very pure neutrophil population, their ability to make IFN-γ 
decreased drastically (Figure 30).  This shows that neutrophils are relatively 



























































Figure 30 IFN-γ response of PMNC isolated from human blood. Polymorphonuclear 
cells isolated from human peripheral blood and positively selected CD15+ 
(Neutrophils) cells were cultured for 24 h in the presence of IL-12, IL-18 and/or live 
B. pseudomallei.   IFN-γ concentrations were determined by ELISA. Filled bars 
represent the crude PMNC, empty bars represent the neutrophils (CD15+). The 














The early hyperproduction of IFN-γ was observed in both the patients with 
severe melioidosis and murine models of B. pseudomallei infection (Brown et al., 
1991; Lauw et al., 1999; Ulett et al., 2000; Liu et al., 2002).  To understand the factors 
contributing to the acute hyperproduction of IFN-γ in response to B. pseudomallei 
infection in the susceptible BALB/c mice as compared to relatively resistant C57BL/6 
mice, we used naïve splenocytes from both mouse strains to examine their response to 
B. pseudomallei.  Our results show that BALB/c splenocytes made more IFN-γ 
compared to C57BL/6 splenocytes when stimulated with live bacteria, mimicking the 
IFN-γ hyperproduction by infected BALB/c mice in vivo. Although the in vitro model 
is an oversimplification as it excludes cell migration dynamics, it provides a 
convenient way of investigating inherent factors that contribute to the propensity of 
BALB/c cells to make IFN-γ in response to live bacteria. However, when stimulated 
with dead bacteria, this trend is reversed, with C57BL/6 splenocytes making more 
IFN-γ than BALB/c.  C57BL/6 and BALB/c mice have generally been classified as 
high and low IFN-γ responders to account for their innate resistance and susceptibility 
to pathogens (De Gee et al., 1985; Huygen et al., 1983).  In response to dead bacteria, 
C57BL/6 splenocytes indeed made more IFN-γ than BALB/c, conforming to this 
model likely through the significantly higher IL-12 production in C57BL/6.  During 
live bacterial infection, there could be additional factors (which was not examined in 
this study) secreted by B pseudomallei that could contribute to impaired control of the 
bacterial load, and difference in the cellular response to infection and cell death. 
These factors might contribute to the differential IFN-γ response in BALB/c and 
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C57BL/6 splenocytes to live bacterial infection and could be the underlying causes 
that contribute to the differential susceptibility observed in vivo.  
 
Our results showed that BALB/c splenocytes were poorer in controlling 
bacterial infection.  This would agree with in vivo data suggesting that high bacterial 
loads lead to hyperproduction of IFN-γ  (Liu et al., 2002; Wongratanacheewin et al., 
2004). It had been reported that peritoneal cells isolated from C57BL/6 mice were 
more potent at microbicidal activity against B. pseudomallei compared to those from 
BALB/c mice (Ulett et al., 1998).   However, higher IFN-γ observed in B. 
pseudomallei infected BALB/c than C57BL/6 splenocytes was not due to difference 
in the cell viability from the two strains of mice, although there could be more subtle 
damages to cells which the XTT assay failed to detect.   
 
Although IL-12 is absolutely essential for IFN-γ production, we found that the 
higher IFN-γ production did not result directly from higher IL-12 concentrations in 
BALB/c when stimulated with live bacteria.  In fact, BALB/c cells made more IL-10, 
abrogation of which increased IFN-γ production.  This means that IL-12 concentration 
is not limiting and differences in IL-10 levels between the mouse strains are not big 
enough to tip the balance in IFN-γ production.  IL-10 and IFN-γ are antagonistic to 
each another (Marchant et al., 1994; D’Andrea et al., 1993; Chomarat et al., 1993). 
IL-10 can inhibit IFN-γ production by NK cells in the presence of antigen presenting 
cells (APCs) through the inhibition of IL-12 (Del Prete et al., 1993; Schroder et al., 
2003).  This could explain why we did not see higher IL-12 level in splenocytes 
culture of BALB/c mice, and it also implies that co-stimulatory factors other than IL-
12 (such as IL-15 and IL-18) were involved in IFN-γ response to B. pseudomallei 
 112
infection (Lertmemongkolchai et al., 2001; Haque et al., 2006).  However, the fact 
that only live bacteria induced IL-10, but dead bacteria did not, suggests that B. 
pseudomallei possess active mechanisms to trigger IL-10 production. In fact, the high 
IL-10 seen in BALB/c in response to live bacteria could be a consequence of the 
system trying to counteract and suppress the increasing inflammation. 
  
We did not find any obvious differences in the cell types making IFN-γ 
between BALB/c and C57BL/6 splenocytes.   However, BALB/c splenocytes 
contained higher numbers of both Gr-1high and Gr-1intermediate cells, as well as NK cells.  
As NK cells are major IFN-γ producers in innate immunity, this translates to more 
IFN-γ.  In addition, we found that Gr-1intermediate cells also contributed to the IFN-γ 
response.  BALB/c splenocytes had higher numbers of Gr-1intermediate expressing CD8 
T cells and NK cells compared to C57BL/6 and could explain why BALB/c cells 
made more IFN-γ.    This apparently requires a live bacterial infection because 
although the same cells made IFN-γ in response to dead bacteria, they did not 
contribute to a higher response in BALB/c.   A live infection allows for various 
pathogenic mechanisms of the bacteria, including the Type III secretion systems 
(TTSS), to operate. This may be necessary to allow for continual activation of cells or 
other factors we did not examine, such as IL-15 which could act as a co-stimulus for 
NK cells to make IFN-γ (Carson et al., 1995), and IL-27 which could act as a co-
stimulus for T cells to induce a high IFN-γ response (Trinchieri, 2003).   Live bacteria 
could also induce caspase-1 activation in macrophages, leading to secretion of IL-1β 
and IL-18 (Sun et al., 2005).  As BALB/c splenocytes constitutively produced more 
IL-18 than C57BL/6, and IL-18 is at least partially required for IFN-γ, this could be 
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an additional factor that contributes to the hyperproduction of IFN-γ in BALB/c 
splenocytes. 
 Several studies in the literature employ Gr-1 antibodies to deplete neutrophils 
in vivo (Buendia et al., 2003; Stephens-romero et al., 2005).  In our cell depletion 
studies, anti-Gr-1 depletion significantly reduced IFN-γ production.  However, since 
Gr-1 stains for both Ly-6G and Ly-6C, we excluded the involvement of neutrophils 
through depletion of Ly-6G+ cells, which represents the Gr-1high cells as Ly-6G is 
found almost exclusively in neutrophils but Ly-6C expression can be found on 
lymphocytes, monocyte/macrophages and NK cells.  This means that the Gr-1 
antibody is also depleting other cell-types expressing Ly-6C or the Gr-1intermediate cells.  
Haque et al. had recently shown F4/80 macrophages to be producing IFN-γ during B. 
pseudomallei infection in vivo (Haque et al., 2006).  We did not further characterize 
the Gr-1intermediate population making IFN-γ, but we did find the expression of Gr-
1intermediate on T cells and NK cells, which likely expresses Ly-6C as Ly-6G is not 
found on these cells.  Others had shown that Ly-6C expressing NK cells (Yahata et 
al., 1996) and CD8+, CD44hi, Gr-1+ T cells make IFN-γ (Matsukaki et al., 2003). As 
BALB/c splenocytes contained more NK cells and Gr-1 expressing NK and T cells, 
this could be another factor contributing to higher IFN-γ production upon live 
bacterial encounter.  Furthermore, we also found through the use of highly purified 
neutrophils that they make very little IFN-γ even in the presence of IL-12 and IL-18 
and minute numbers of contaminating lymphocytes in neutrophil preparations could 
contribute to the IFN-γ effect.  Thus, it is imperative for studies examining the 
production of IFN-γ by neutrophils to use highly purified neutrophils and to exclude 
the contribution of contaminating cell-types.    For the depletion of CD4+ and  CD8+ 
cells, other cells such as CD11c+ dendritics cells which coexpress either CD4 or CD8 
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might be depleted from the total splenocytes. Therefore, CD8 beta which is found to 
be exclusively expressed on T cells would be a more suitable marker for depletion of 
CD8+ cells. In fact, Schleicher et al. recently found that minute numbers of 
contaminating CD8+ T cells or CD11b+CD11c+NK cells are the source of IFN-γ in IL-
12/IL-18-stimulated mouse macrophage populations (Schleicher et al., 2005). This 
highlights the need for caution in interpreting data due to the possible presence of 
minute numbers of contaminating but high IFN-γ producing cells.   
 
            Lipopolysaccharide is one of the most potent pathogen associated molecular 
patterns (PAMPs) in Gram negative bacteria during sepsis. We found that LPS is 
essential for IFN-γ response to heat-killed bacteria, but it is dispensable in the IFN-
γ production to live bacteria. Based on the results from C3H/HeJ splenocytes, we 
confirm the essential role of TLR-4 signaling in the IFN-γ response to heat-killed 
bacteria. TLR signaling pathways are diverse and yet there are common intermediates 
for different pathways, which may crosstalk at the downstream pathways. Therefore, 
active infection with B. pseudomallei would allow additional PAMPs to be secreted, 
or come into contact with the splenocytes to activate other TLRs other than TLR-4 
and hence bypass the need for TLR-4 signaling. Preliminary data from our laboratory 
has shown that active infection with B. pseudomallei strain KHW could lead to 
activation of NF-κB in 293T cells in the absence of TLR transfection. This could be 
another explanation for the induction of IFN-γ in the absence of functional TLR-4 
signaling. Further study is needed for verification of different possibilities. 
 
  In conclusion, our results show that an active infection is required to induce a 
hyperproduction of IFN-γ in BALB/c compared to C57BL/6.  This is not due to 
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higher IL-12 levels, although IL-18 is higher in BALB/c splenocytes.  Intracellular 
bacterial loads are higher in BALB/c splenocytes, which would contribute to more 
inflammation.  Furthermore, the higher numbers of NK cells and those expressing Gr-
1 intermediate as well as more IL-18 in BALB/c splenocytes could also give rise to more 
IFN-γ.  Investigations into how each cell population interacts with live bacteria could 


























We established a mucosal infection model showing differential susceptibility 
to virulent B. pseudomallei infection using two inbred mouse strains, the BALB/c and 
C57BL/6 mice. BALB/c mice were relatively susceptible to intranasal B. 
pseudomallei infection compared to C57BL/6 mice. Susceptibility correlates with 
lower LD50 value, higher bacterial loads (especially in the lung and spleen), more 
severe pathology (particularly in the lung and spleen), and hyper-inflammmation with 
splenic and local IFN-γ response being the most prominent. This animal model has 
been instrumental in our efforts to identify correlates of innate immunity and factors 
contributing to host resistance and susceptibility. The infection of relatively resistant 
C57BL/6 mice with high dose of bacteria has revealed the importance of the control 
of bacterial growth during the early stage of infection. In the presence of high dose of 
B. pseudomallei, the relatively resistant C57BL/6 also succumb to infection and 
developed similar pathology and characteristics resembling that of low dose infection 
in susceptible BALB/c mice. The presence of bacteria in the blood indicates the 
systemic spread of bacteria within the first 24 hours post-infection. The clearance of 
bacteria from the blood circulation required 3-4 days, but the bacterial loads in the 
organs (especially lung, liver, spleen and brain) of infected mice remained high. In 
this infection model, neutrophils were the major infiltrating cells. Thus, under a low 
dose infection, there could be innate control mechanisms found only in the C57BL/6 
mice (such as the low basal level of IFN-γ) that enable the control of bacterial growth 
during the early time points. Such protective mechanisms may be absent in the 
BALB/c mice, where overwhelming growth and spread of bacteria lead to septicemia. 
It remains to be confirmed whether impaired killing of bacteria by the innate cells 
leads to the septicemic infection. 
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To examine the innate susceptibility and resistance further, we compared the 
innate cytokine response of splenocytes between BALB/c and C57BL/6 mice in vitro. 
Splenocytes from BALB/c mice were found to produce significantly higher level of 
IFN-γ compared to splenocytes from C57BL/6 mice in response to live bacterial 
infection. The differential IFN-γ response to bacteria infection was not due to 
different in cell viability, but was a result of poorer bacterial control at the first few 
hours of infection with B. pseudomallei in the relatively susceptible BALB/c 
splenocytes. In addition, BALB/c splenocytes produced higher levels of other 
proinflammatory cytokines including TNFα, IL1-β, IL-6, higher basal IL-18, and 
stronger anti-inflammatory cytokine (IL-10) compared to the splenocytes of C57BL/6 
mice after infection with B. pseudomallei. However, there was no difference in the IL-
12 response between the infected splenocytes from the two mouse strains meaning 
that the difference in IFN-γ response was not contributed by higher IL-12 in BALB/c 
mice. Using the blocking with antibodies against cytokines, IL-12 and IL-18 were 
both required for optimal production of IFN-γ, whereas the presence of IL-10 was 
inhibitory to IFN-γ response. We found that T cells (both CD4, CD8 T cells), NK 
cells were the most important producers of IFN-γ in vitro, majority of these cells are 
NK and CD8+ expressing Gr-1 marker. Since splenocytes from nude mice could still 
produce strong IFN-γ, indicating a redundant role of T cells in IFN-γ production, the 
higher percentage of NK cells in the splenocytes of nude mice could be compensatory 
in the absence of functional T lymphocytes. We also found that both in mice and 
human neutrophils were not the major cell type producing IFN-γ  contrary to what 
some studies in the literature suggest. 
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Besides characterization of the mucosal infection model and the innate 
resistance to disease, we also characterized the humoral immune responses in r-FliC 
immunized BALB/c mice and the low dose-high dose B. pseudomallei infected 
C57BL/6 mice. The results showed that, although strong antigen-specific IgG 
response was elicited in the FliC immunized mice, there was only a slight delay in 
host death after infection when FliC was administered with CTB, and such response 
was not efficient in preventing host death. This could be due to the induction of a 
strong FliC specific IgG response of the predominantly IgG1 subtype (indication of 
Th2 dominant immunity), and there was enhancement of Th2 response in the presence 
of CTB. The protection of the surviving, low-dose infected C57BL/6 mice against 
subsequent high dose bacteria challenge, on the other hand, correlates with the 
induction of strong antibody responses characterized by strong total IgG and a 
predominant IgG2a subtype antibody, indicating the presence of IFN-γ response 
(which is required for IgG class-switching) and the involvement of cell mediated 
immunity. However, some low dose immunized C57BL/6 mice eventually died before 
or after high dose challenge demonstrating an incomplete resistance. Since live 
infection is non-applicable in any vaccine approaches in humans and the associated 
risks are high, future study on vaccine development should involve immunization 
with combination of antigens that have the potential to stimulate a long term Th1 cell 
mediated immune response as well as antibody response of the Th1 type having 
strong IgG2a antibody specific to the bacteria. This would likely involve using 
adjuvants or delivery vectors which could help to stimulate a Th1 type response. 
 
            In brief, we have characterized a mucosal infection model showing differential 
susceptibility to intranasal infection with B. pseudomallei. The innate susceptibility is 
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linked to the inability to control bacterial growth, while the innate resistance 
correlates to the ability to control bacterial growth. BALB/c mice developed 
hyperinflammation due to uncontrolled growth of bacteria, and such response did not 
confer protection and could be the major cause of pathology. The control of bacterial 
infection in the ensuing adaptive immunity likely required the IgG2a antibody 
indicative of Th1 response. This understanding is important in the design of future 
vaccine. 
 
 A recent study by Haque et al (2006) demonstrated that T cells play important 
roles in both innate and adaptive immunity to confer long-term protection against B. 
pseudomallei infection. Therefore, induction of potent protective cellular immunity 
against B. pseudomallei should be the key to successful vaccine development. Since 
recombinant flagellin did not confer sufficient protection in the intranasal 
immunization, other immunogenic antigens should therefore be screened and tested 
for their ability to confer protection. In addition, the use of CTB did not contribute to 
significant protection. Thus, future study on vaccine development should use other 
adjuvants (such as CpG DNA and alum) that stimulate a strong Th1 response. To 
establish the role of antigen specific antibodies, experiments that involve the adoptive 
transfer of serum from immunized mice into naïve mice and test for protection against 
B. pseudomallei infection should be carried out. Furthermore, cell-mediated immunity 
induced by protective antigens should also be studied in detail.  
 
              Our results and others (Santanirand et al., 1999) suggest the importance of 
early IFN-γ response in the control of B. pseudomallei infection. However, whether 
hyperproduction IFN-γ has any pathological role during acute melioidosis remains 
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unknown. Future study should include the injection of IFN-γ neutralizing antibody 
into BALB/c mice after infection to establish the exact role of IFN-γ in acute 
melioidosis. Besides, the studies on the roles of chemokines and chemokines 
receptors in relation to mediators such as IL-10 and GM-CSF, in both innate and 
adaptive immunity may also shed new light in the understanding of 
immunopathogenesis of Burkholderia pseudomallei infection.  
 
As the host-pathogen interaction is a very complicated process, future studies 
should include studying the interactions between various innate immune cells found 
in the splenocyte populations with the bacteria, particularly the macrophages and 
dendritic cells. Because these are the major innate immune cells which involve in 
shaping of adaptive immune responses through their antigen presenting function, and 
interaction with T cells. Owing to the fact that disease susceptibility or resistance 
involves complex mechanisms and various host factors, Quantitative Trait Loci study 
(QTL) should therefore be helpful in the identification of genetic loci which 
contribute to resistance or susceptibility through crossbreeding of resistant and 
susceptible animals and examining how their progeny response to infection. The 
identification of susceptibility loci in mice and their homologs in human will help in 
prediction of disease outcome. Those who are genetically susceptible to the infection 
should be advised to avoid traveling to the endemic regions and they should be 
vaccinated (if the vaccine is available). These studies will help us to understand more 
about the host factors associated with infection, and allow strategic design of 
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Appendix I: Recipes 
 
1.1 Media for bacteria culture 
 
Tryptic Soy Agar (TSA): 15.0 g/L bacto-tryptone, 5. g/L soya peptone, 5.0 g/L  
                                            NaCl, 15.0 g/L agar, pH 7.3. 
 
 
Ashdown slective medium: 10 g/L TSA, 4 % glycerol (w/v), 5 mg/L crystal violet,   
                                               50 mg/L neutral red and 4 mg/L gentamicin. 
 
LB broth: 10 g/L bacto-tryptone, 5 g/L bacto yeast extract, 5 g/L NaCl, pH 7.0. 
 
LB agar: LB medium containing 15 g/L bactor agar. 
 
• All the media used for bacteria culture were sterilized by autoclaving at 121 
°C, 15 PSI for 15 min. 
 
1.2 Supplements 
Kanamycin stock solution: 25 mg/ml in H2O, sterile filter, store in aliquots at – 20 °C.  
Ampicillin stock solution: 50 mg/ml in H2O, sterile filter, store in aliquots at – 20 °C.  
Gentamicin stock solution: 100 mg / ml in H2O, sterile filter, store in aliquots at – 20 °C. 
IPTG (1M): 238 mg/ml in H2O, sterile filter through 0.22 μm filter, store in aliquots  
                    at – 20 °C.  
 
1.3 Buffers for purification under denature conditions: 
Buffer B: 100mM NaH2PO4 , 10 mM Tris HCL, 8 M Urea, pH 8.0 
Buffer C: 100mM NaH2PO4 , 10 mM Tris HCL, 0.5 % Sodium deoxycholate, 8 M    
                 Urea, pH 6.3 
 
Buffer D: 100mM NaH2PO4 , 10 mM Tris HCL, 8 M Urea, pH 5.9 
Buffer E: 100mM NaH2PO4 , 10 mM Tris HCL, 8 M Urea, pH 4.5 
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1.4 Reagents for SDS-PAGE 
Resolving Gel (8%) 
 2 Gels 1 Gel 
Solution D 10.5 ml 5 ml 
ddH2O  4.2 ml 2 ml 
Solution A 4.2 ml 2 ml 
1 % SDD 2.1 ml 1 ml 
10% APS* 105 μl 50 μl 
TEMED* 10.5 μl 5 μl 
 
Stacking Gel (4%) 
 2 Gels 1 Gel 
Solution C 2.5 ml 1.25 ml 
ddH2O  1.5 ml 750 μl 
Solution A 0.5 ml 250 μl 
1 % SDD 0.5 ml 250 μl 
10% APS* 12.5 μl 6.25 μl 
TEMED* 10 μl 5 μl 
 
Solution A (Bis-acrylamide): acrylamid 45 g, bis-acryalmide 1.2 g, H2O 100 ml. 
Solution B (5x running buffer): 15.14 g Tris (125 mM), 72 g glycine (0.96 M), 5 g                          
                                                         SDS (0.5 %), top up with H2O to 1 liter, pH 8.3.  
 
Solution C (Stacking buffer): 30.28 g Tris (0.25 M), top up with H2O to 1 liter,  
                                                   pH 6.8. 
 
Solution D (Resolving buffer): 90.9 g Tris (0.75M), top up with top up with H2O to  
                                                   1 liter, pH 8.8. 
 
Solution F (Ammonium persulfate): .0.03 g APS in 300 μl H2O (10%). 
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SDS-PAGE running buffer: 25 mM Tris-base, 0.19 M glycine, 0.1 % (w/v) SDS,  




Coomassie Blue Staining 
Fixing solution for SDS-PAGE: 
Glacial acetic acid: methanol: H2O = 10: 50: 40  
Staining solution: 
0.05 % Coomassie blue 
Glacial acetic acid: methanol: H2O = 10: 50: 40 
 
Destaining solution: 
Glacial acetic acid: methanol: H2O = 7: 5: 88 
 
1.5 Buffers for ELISA 
10X PBS: 
 
8 % (w/v) NaCl, 8 g/L 
0.2 % (w/v) KCl, 0.2 g/L 
1.44 % Na2HPO4, 1.44 g/L 
0.24 % KH2PO4, 0.24 g/L 
Adjust to pH 7.4 
 
Bicarbonate coating buffer: 1.59 g Na2CO3, 2.93 g NaHCO3, top up to 1 L with  
                                                H2O. pH 9.5  
 
Wash buffer PBST: 500 μl Tween 20 to liter 1×PBS. 
Assay buffer (0.5 % BSA-PBST): 0.5 g of BSA was dissolved in 100 ml PBST. 
 
1.6 Buffer for flowcytometry staining 
Fixing buffer: 2 % parafolmadehyde in 1 x PBS 
Permeabilization/wash buffer: 0.1 % saponin- 1 % FBS – 1 x PBS 
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